fluorodeoxyglucose f18 has been researched along with Inflammation in 646 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.15) | 18.7374 |
| 1990's | 7 (1.08) | 18.2507 |
| 2000's | 109 (16.87) | 29.6817 |
| 2010's | 341 (52.79) | 24.3611 |
| 2020's | 188 (29.10) | 2.80 |
| Authors | Studies |
|---|---|
| Freeburg, LA; Herzog, E; Miller, EJ; Moreland, H; Oatmen, KE; Shahab, Z; Spinale, FG; Young, BD | 1 |
| Ayappa, I; Fayad, Z; Kundel, V; Mani, V; Redline, S; Reid, M; Rueschman, M; Shah, N; Shea, S | 1 |
| Arora, K; Barry, CE; Cai, Y; Chen, RY; Dawson, R; Diacon, AH; Gao, J; Goldfeder, LC; Jin, X; Liu, X; Malherbe, ST; Pan, S; Qu, Y; Smith, B; Tameris, M; Thienemann, F; Vincent, J; Walzl, G; Wang, J; Wilkinson, RJ; Yu, X; Zhang, R; Zhu, H | 1 |
| Abe, T; Bekki, M; Fukumoto, Y; Honda, A; Igata, S; Imai, S; Kaida, H; Maeda-Ogata, S; Okabe, Y; Otsuka, H; Sugiyama, Y; Tahara, A; Tahara, N; Tanaka, H; Tayama, E; Ushijima, T | 1 |
| Bijzet, J; Boots, AMH; Brouwer, E; de Jong, DM; Esen, I; Heeringa, P; Jiemy, WF; Nienhuis, PH; Slart, RHJA; van Sleen, Y | 1 |
| Miller, EJ; Park, J; Young, BD | 1 |
| Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM | 1 |
| Chen, M; Kapoor, P; Keel, A; Manyak, G; Mehta, NN; Osborne, MT; Pantoja, C; Parel, P; Patel, NH; Playford, MP; Rodante, JA; Scott, C; Sorokin, AV; Svirydava, M; Tawakol, A; Teague, H; Teklu, M; Zhou, W | 1 |
| Beanlands, RSB; Boczar, KE; Corrales-Medina, VF; deKemp, RA; Dwivedi, G; Faller, E; MacPherson, P; Small, GR; Wang, J; Ward, NC; Zeng, W | 1 |
| Holzinger, J; Lakomek, HJ; Reinbold, WD; Witte, F | 1 |
| Abo, Y; Akikusa, J; Burgner, D; Danchin, MH; Francis, P | 1 |
| Prigent, K; Vigne, J | 1 |
| Grönroos, TJ; Ilomäki, MA; Polari, L; Ridge, KM; Stenvall, CA; Tayyab, M; Toivola, DM; Viiri, K | 1 |
| Besutti, G; Boiardi, L; Casali, M; Ferrari, M; Galli, E; Giorgi Rossi, P; Ligabue, G; Mancuso, P; Marvisi, C; Monelli, F; Muratore, F; Pattacini, P; Salvarani, C; Spaggiari, L; Versari, A | 1 |
| Aigner, RM; Nazerani Hooshmand, T; Pernthaler, B; Sorantin, E; Weitzer, F | 1 |
| Kim, SH; Lee, SJ; Park, DW; Sohn, JW; Yoon, HJ | 1 |
| Aguilera-Simón, A; Benitez, S; Camacho, M; Camps-Renom, P; Fernández-León, A; Jiménez-Altayó, F; Jiménez-Xarrié, E; Marín, R; Martí-Fàbregas, J; Puig, N; Sánchez-Quesada, JL | 1 |
| Bonino, F; Brunetto, MR; Cacciato Insilla, A; Campani, D; Guzzardi, MA; Iozzo, P; La Rosa, F; Nannipieri, M | 1 |
| Edenbrandt, L; Enqvist, O; Gerke, O; Høilund-Carlsen, PF; Larsson, M; Nøddeskou-Fink, AH; Piri, R; Stochkendahl, MJ | 1 |
| Bentsen, S; Binderup, T; Grandjean, CE; Jensen, JK; Kjaer, A; Ripa, RS | 1 |
| Kim, SH; Lee, SJ | 1 |
| Bezerra Pinheiro, RB; Buchpiguel, CA; Ceconello, I; Mester, M; Ribeiro, U; Sado, HN; Sallum, RAA; Simionato Perrotta, F; Sobroza de Mello, E; Tustumi, F; Zilberstein, B | 1 |
| Bax, JJ; Stassen, J; van der Bijl, P | 1 |
| Alavi, A; Høilund-Carlsen, PF; Khurana, N; Park, PSU; Werner, TJ | 1 |
| Chang, H; Joo, KJ; Kim, SJ; Kim, YH; Ryu, S; Youn, I | 1 |
| Andrés, V; Bueno, H; Devesa, A; España, S; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, JJ; Fuster, V; García-Lunar, I; Ibanez, B; Lobo-González, M; Martínez-Milla, J; Mastrangelo, A; Mendiguren, JM; Oliva, B; Rossello, X; Sanchez-Gonzalez, J; Sancho, D; Sanz, J | 1 |
| Alavi, A; Høilund-Carlsen, PF; McDonald, E; Park, PSU; Raynor, WY; Singh, SB; Werner, TJ | 1 |
| Imajo, M; Ishibashi, M; Kanenishi, K; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tanaka, T; Tsuruta, T; Yamamoto, Y | 1 |
| Álvaro-Gracia, JM; Castrejón, I; González, C; López, K; Martínez-Barrio, J; Molina-Collada, J; Montero, F; Nieto-González, JC; Rivera, J; Trives, L | 1 |
| Alavi, A; Hunt, SJ; Saucedo, J; Vossough, A; Zandifar, A | 1 |
| Jaleel, J; Kumar, R; Sagar, S | 1 |
| Berg, AR; Chen, M; Dey, A; Hong, CG; Li, H; Mehta, NN; Parel, P; Playford, M; Schwartz, DM; Siegel, E; Sorokin, AV; Sylvester, M; Teague, H | 1 |
| Kadoglou, NP; Khattab, E; Lambadiari, V; Patsourakos, N; Velidakis, N | 1 |
| Ahlman, MA; Alessi, HD; Grayson, PC; Luo, Y; Novakovich, E; Quinn, KA; Saboury, B | 1 |
| Eugene, T; Fellah, I; Guyomarch, B; Jamet, B; Marteau, L; Piriou, N; Probst, V; Sébille, JC; Serfaty, JM; Tessier, R; Thollet, A; Toquet, C; Trochu, JN; Vivien, M; Warin-Fresse, K | 1 |
| Cb, V; Das, SS; Malik, D; Manda, D; Sen, I; Thakral, P | 1 |
| Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Iemura, M; Kagiyama, Y; Kishimoto, S; Nakamura, T; Suda, K; Tahara, N | 1 |
| Ashton, NJ; Benedet, AL; Blennow, K; Cacciaglia, R; Falcon, C; Fauria, K; Gispert, JD; Kollmorgen, G; Milà-Alomà, M; Minguillon, C; Molinuevo, JL; Niñerola-Baizán, A; Operto, G; Perissinotti, A; Salvadó, G; Shekari, M; Suárez-Calvet, M; Suridjan, I; Wild, N; Zetterberg, H | 1 |
| Betrains, A; Blockmans, D; De Langhe, E; Moreel, L; Vanderschueren, S | 1 |
| Fukazawa, R; Igarashi, T; Isobe, M; Itoh, Y; Narazaki, H; Tanabe, Y; Watanabe, M; Yamanishi, S | 1 |
| Aebersold, DM; Alberts, I; Bojaxhiu, B; Elicin, O; Rominger, A; Shelan, M; Sinovcic, D; Templeton, AJ; Wartenberg, J; Zaugg, K | 1 |
| Bathon, JM; Ferraz-Amaro, I; Giles, JT; Polack, B; Sheikh, A | 1 |
| Sookaromdee, P; Wiwanitkit, V | 1 |
| Calcagni, ML; Carli, G; Kiferle, L; Martini, AL; Morbelli, S; Palumbo, P; Perani, D; Piersanti, P; Sestini, S | 1 |
| Al-Harrasi, A; Ali, A; Aziz, S; Cao, S; Chen, KH; Corcoran, E; Elliot, G; Elsharabasy, RM; Emara, AA; Fan, DD; Fayez, M; Funk, T; Ghareeb, AH; Gu, X; Guo, M; Halim, SA; He, Q; He, Z; Hu, K; Iqbal, A; Iqbal, M; Khan, A; Kurtulus, S; Lam, J; Lee, J; Li, Y; Liu, J; Liu, Z; Long, L; Lu, H; Mao, Z; Meyer, MJ; Molony, RD; Piquet, M; Qu, F; Ruddy, D; Shen, L; Song, J; Sun, J; Tang, J; Tang, Y; Trabucco, G; Varadarajan, M; Wang, HQ; Wang, Q; Waqas, M; Xia, C; Yang, FM; Yang, L; Yang, Y; Zeng, X; Zhang, G; Zhang, T; Zhang, X; Zhou, M; Zhou, Y; Zhou, Z; Zhu, Z | 1 |
| Barreto, MM; Basílio, R; Bozza, FA; Bozza, PT; Carvalho, ARS; de Almeida, SA; de Toledo-Mendes, J; Hottz, ED; Martins, PAG; Martins-Gonçalves, R; Motta Ribeiro, G; Rodrigues, RS; Rosado-de-Castro, PH; Zin, WA | 1 |
| Dong, J; Du, X; Li, Q; Li, S; Liu, T; Lv, Q; Ma, C; Wang, H; Xiong, R; Yang, X | 1 |
| Jensen, JK; Jensen, MEK; Kjaer, A; Madsen, JS; Ripa, RS | 1 |
| Cheng, Z; Ma, C; Wang, X | 1 |
| Greulich, S; Krumm, P; la Fougère, C; Nikolaou, K | 1 |
| Harada, M; Otomi, Y; Otsuka, H; Shinya, T; Shono, N | 1 |
| Ahmed, S; Bogoni, G; Carneiro-Ramos, MS; Carvalho, MK; Castanheira de Souza, NF; Cen, P; Champlin, R; Cherng, HJ; Clark, AH; Dağ, İ; Djawad, K; Ertaş, S; Fayad, L; Feng, L; Ferri, D; Flowers, CR; Gonca Okumuş, Z; González-Lafuente, L; Gu, W; Hagemeister, F; He, Q; Imaizumi, U; Imura, M; Jiang, H; Junho, CVC; Kagawa, K; Kaneko, D; Kebriaei, P; Kido, K; Kishimoto, N; Kröcher, O; Kurata, S; Kuroda, H; Lee, HJ; Liu, XH; Lucas Júnior, RM; Ma, L; Macapinlac, HA; Massi, MN; Miskad, UA; Nachtegaal, M; Nair, R; Nastoupil, LJ; Navarro-García, JA; Neelapu, SS; Neres-Santos, RS; Nieto, Y; Patellongi, IJ; Pinnix, CC; Ramdial, J; Reis Schneider, GA; Rezvani, K; Rodriguez, M; Rodríguez-Sánchez, E; Ruiz-Hurtado, G; Rusinovich, V; Rusinovich, Y; Safonova, OV; Sanuki, T; Shi, JB; Shpall, E; Srour, S; Steiner, R; Strati, P; Sudagidan, M; Tian, M; Tsukimoto, S; Turhan, U; Ünver, G; Vidal, JE; Wang, M; Wang, YM; Westin, J; Wu, L; Xiao, Y; Xu, G; Xu, Y; Yan, YY; Yegin, Z; Yılmaz, S; Yu, K; Yusuf, I; Zabilska, A; Zhang, H; Zhang, Q; Zhang, X; Zhang, XX | 1 |
| Kupari, M; Lehtonen, J; Niemelä, M; Pöyhönen, P; Schildt, J; Uusitalo, V | 1 |
| Alavi, A; Armstrong, AW; Blauvelt, A; Fitzsimmons, R; Gelfand, JM; Gottlieb, S; Kalb, RE; Lockshin, BN; Manyak, GA; Mehta, NN; Mendelsohn, L; Noe, MH; Papadopoulos, M; Parel, P; Playford, MP; Rodante, J; Shin, DB; Syed, MN; Tyring, SK; Wan, J; Werner, TJ | 1 |
| Avery, AK; Bowman, E; Durieux, JC; Funderburg, N; Hileman, CO; Janus, SE; Kettelhut, A; McComsey, GA; Nguyen, TT; Sullivan, C | 1 |
| Campisi, R; Merani, MF; Rodríguez, MI | 1 |
| Bentick, G; Day, J; Fairley, J; Nadesapillai, S; Wicks, I | 1 |
| Blankstein, R; Divakaran, S | 1 |
| Ikegami, H; Inui, S; Ishii, H; Kuji, I; Musha, Y; Okuno, Y; Sakamoto, M; Shintaku, T; Yoshizawa, S | 1 |
| Alavi, A; Lau, HC; Naseer, R; Ng, SJ; Raynor, WY; Sandhu, S; Werner, TJ | 1 |
| Gopalan, D; Tarkin, JM | 1 |
| Almeida Schirmer, BG; Batista Silva, J; de Araújo Bispo, AC; de Oliveira Silva, J; Faria Almeida, FA; Mamede, M; Melo Mendes, B; Vidal Ferreira, A | 1 |
| Beanlands, RSB; Boczar, KE; Chirinos, JA; Corrales-Medina, V; deKemp, RA; Dwivedi, G; Tavoosi, A | 1 |
| Mistry, NP; Zeng, W | 1 |
| Higashi, T; Ishizu, K; Okuyama, C; Saga, T | 1 |
| Abe, T; Bekki, M; Fukumoto, Y; Fukuoka, R; Honda, A; Igata, S; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
| Giovanella, L; Knappe, LM; Librizzi, D; Luster, M; Verburg, FA | 1 |
| Alpendurada, F; Azzu, A; Baksi, J; Gardezi, SKM; Hatipoglu, S; Izgi, C; Khattar, R; Kouranos, V; Mohiaddin, R; Pennell, DJ; Sharma, R; Wechalekar, K; Wells, AU | 1 |
| Jayawickrama, W; Martin, J; Otome, O; Vijayaraghavan, N | 1 |
| Abe, Y; Ashizawa, K; Kawamata, N; Makiyama, A; Tamura, N | 1 |
| Kim, DW; Kim, MH; Park, SA | 1 |
| Brandon, DC; Dibble, EH; Keidar, Z; Kwak, JJ; Palestro, CJ | 1 |
| Franc, B; Khessib, T; Moradi, F; Yang, E | 1 |
| Abe, K; Aoki, K; Daimon, M; Iwahana, T; Kato, H; Kobayashi, Y; Ono, R | 1 |
| Betrains, A; Blockmans, D; Boeckxstaens, L; Moreel, L; Van Laere, K; Vanderschueren, S; Wright, WF | 1 |
| Beanlands, RS; Boczar, KE; deKemp, RA; Dwivedi, G; Fehlmann, CA; Glassman, SJ; Karsh, J; Wang, J; Ward, NC; Wells, GA; Zeng, W | 1 |
| Assaraf, M; Bois, M; Bold, MS; Espitia, O; Frota Lima, LM; Koster, MJ; Lades, G; Liozon, E; Ly, KH; Parreau, S; Saadoun, D; Warrington, KJ; Weyand, CM | 1 |
| Aguilera-Simón, A; Benitez, S; Benitez-Amaro, A; Camps-Renom, P; Fernández-Leon, A; Garcia, E; Jiménez-Xarrié, E; Llorente-Cortés, V; Martí-Fàbregas, J; Puig, N; Sanchez-Quesada, JL; Solé, A; Vilades, D | 1 |
| Al-Obaydi, N; Bentestuen, M; Zacho, HD | 1 |
| Darwiche, K; Fendler, WP; Hautzel, H; Herrmann, K; Meetschen, M; Moter, A; Opitz, M; Sandach, P; Schaarschmidt, BM; Theegarten, D | 1 |
| di Santo, G; Sviridenko, A; Virgolini, I | 1 |
| Bauckneht, M; Camellino, D; Cimmino, MA; Cutolo, M; Hysa, E; Iannuzzi, F; Morbelli, S; Sambuceti, G | 1 |
| Aarntzen, EHJG; Janssen, AWM; Riksen, NP; Stienstra, R; Tack, CJ; van Diepen, JA; van Heck, JIP | 1 |
| Betrains, A; Blockmans, D; Moreel, L; Vanderschueren, S; Wright, WF | 2 |
| Kim, B; Kim, H; Kim, K; Kim, MB; Kim, SJ; Ko, HC; Lee, GW; Shin, K | 1 |
| Adams, DH; Boateng, P; Devesa, A; Dukkipati, SR; El-Eshmawi, A; Fayad, ZA; Liao, SL; Miller, MA; Pandis, D; Pyzik, R; Reddy, VY; Robson, PM; Trivieri, MG | 1 |
| Hansen, T; Kuzniar, M; Mani, K; Tegler, G; Wanhainen, A | 1 |
| De Lacerda, PGLN; De Souza, ACS; De Souza, SAL; Jardim, MR; Lara, FA; Penna, PS; Pinheiro, RO; Rodrigues Pitta, IJ; Sales, AM; Sarno, EN; Spitz, CN | 1 |
| Akyüz Dağlı, P; Armağan, B; Coşkun, N; Doğan, İ; Erten, Ş; Güven, SC; Karakaş, Ö; Maraş, Y; Orhan, K; Türkölmez, Ş | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Abohashem, S; Arechiga, VM; Chow, FC; Epel, ES; Hsue, PY; Iaccarino, L; La Joie, R; Mundada, NS; Rabinovici, GD; Swaminathan, S; Tawakol, A | 1 |
| Alavi, A; Gerstenblith, G; Harb, T; Latina, JM; Leucker, TM; Safiullah, ZN; Schindler, TH; Valenta-Schindler, I; Ziogos, E | 1 |
| Kloiber, R; Koslowsky, IL; Lafford, HW; Rabin, HR; Stewart, EE | 1 |
| Abou Ezzeddine, OF; Ackerman, MJ; Bois, JP; Cooper, LT; Fink, AL; Garmany, R; Giudicessi, JR; Homb, AC; MacIntyre, CJ; McLeod, CJ; Neves, R; Pereira, NL; Rosenbaum, AN; Siontis, KC; Tseng, AS | 1 |
| Craig, NJ; Dweck, MR | 1 |
| Barry, M; Camps-Renom, P; Cassidy, T; Cronin, S; Dolan, E; Fernández-León, A; Foley, S; Giannotti, N; Gorey, S; Harbison, J; Kelly, PJ; Marnane, M; Martí-Fabregas, J; McCabe, JJ; McNulty, JP; O'Connell, M; Williams, DJ | 1 |
| Abe, Y; Makiyama, A; Sakuma, S; Takeuchi, M; Tamura, N | 1 |
| Chudek, J; Nalewajka-Kołodziejczak, J; Ochmann, A; Winder, M | 1 |
| Bhakta, S; Evans, NR; Gorey, S; Kelly, PJ; McCabe, JJ; Rudd, JHF | 1 |
| Cesmecioglu, E; Dede, F; Karaman, D; Kesim, S; Turoglu, HT | 1 |
| Chai, L; Chen, L; Cheng, Z; Cui, X; Duan, Y; Ge, M; Li, H; Li, K; Ng, YL; Quan, W; Wang, X; Zan, K; Zhao, M; Zhou, Y | 1 |
| Ashton, NJ; Blennow, K; Chiotis, K; Graff, C; Johansson, C; Nordberg, A; Rodriguez-Vieitez, E; Zetterberg, H | 1 |
| Braskie, MN; Chui, HC; Hapenney, M; King, K; Mack, WJ; Matsiyevskiy, E; Thompson, PM; Tubi, MA; Wheeler, K | 1 |
| Iijima, Y; Ishikawa, M; Iwai, S; Mizoguchi, T; Motono, N; Uramoto, H | 1 |
| Lavine, KJ; Liu, Y; Thackeray, JT | 1 |
| Ahmadi, A; Beanlands, R; Boczar, KE; Chong, AY; deKemp, RA; Dowlatshahi, D; Garrard, L; Kelly, C; Lefebvre, C; Leung, E; Liu, P; Lochnan, H; MacPhee, P; MacPherson, PA; Raggi, P; Shin, S; Tavoosi, A; Tawakol, A; Tilokee, E; Torres, C; Wells, GA; Wiefels, C | 1 |
| Alhaskawi, A; Dong, M; Dong, Y; Ezzi, SHA; Hasan Abdulla, MHA; Huang, Y; Kota, VG; Li, P; Liu, Z; Lu, H; Su, X; Tu, T; Wang, Z; Zhou, H | 1 |
| Divakaran, S; Osborne, MT | 1 |
| Adedjouma, A; Buvat, I; Fain, O; Laurent, C; Mekinian, A; Ricard, L; Soussan, M | 1 |
| Beanlands, RS; Corrales-Medina, VF; deKemp, RA; Dwivedi, G; Glassman, SJ; Habibi, CM; MacPherson, P; Wang, J | 1 |
| Chuang, TL; Huang, SW; Tseng, CE; Wang, YF | 1 |
| Demircioglu, A; Forsting, M; Herrmann, K; Juette, H; Koch, AK; Langhorst, J; Li, Y; Martin, O; Schaarschmidt, B; Tannapfel, A; Umutlu, L | 1 |
| Bengs, S; Buechel, RR; Burger, IA; Fiechter, M; Fuchs, TA; Gebhard, C; Haider, A; Kaufmann, PA; Marędziak, M; Messerli, M; Pazhenkottil, AP; Portmann, A; Roggo, A; Schade, K; Treyer, V; Warnock, GI | 1 |
| Gao, W; Tian, Y; Wang, J; Wang, Y; Xi, XY; Xu, H; Xu, M; Yang, MF; Zhang, F | 1 |
| Jiang, Y; Li, L; Li, M; Wu, W; Zhang, P | 1 |
| Dharmakumar, R; Goldhawk, DE; Prato, FS; Thiessen, JD; Wilk, B; Wisenberg, G | 1 |
| Aarntzen, EHJG; Deinum, J; Hoischen, A; Joosten, LAB; Kaffa, C; Kersten, S; Monajemi, H; Netea, MG; Noz, MP; Riksen, NP; Smeets, EMM; van der Heijden, CDCC | 1 |
| de Almeida, SA; de Brito, ASX; de Oliveira, RS; de Sousa, AS; Moll-Bernardes, RJ; Rosado-de-Castro, PH | 1 |
| Miller, EJ | 1 |
| Li, F; Luo, Y; Pan, Q; Zhang, W | 1 |
| Kim, EJ; Kim, S; Lee, YJ; Pahk, K; Seo, HS | 1 |
| Cheng, C; Hou, Q; Hua, F; Li, X; Li, XF; Li, Y; Miao, W; Wang, Q; Wang, X; Wu, H; Yao, Z; Zhang, W; Zhang, X; Zhu, X | 1 |
| Akazawa, T; Aoki, M; Asano, T; Inoue, N; Ito, Y; Kato, H; Kuze, B; Matsuo, M; Miyazaki, T; Ohashi, T; Shibata, H; Terasawa, K | 1 |
| Li, XG; Ohrndorf, S; Roivainen, A; van der Laken, CJ | 1 |
| Gormsen, LC; Hess, S; Scholtens, AM | 1 |
| Al Najafi, M; Dey, AK; Mehta, NN; Reddy, AS; Uceda, DE | 1 |
| Kircher, M; Lapa, C | 1 |
| Aryal, SR; Bajaj, NS; Bansal, NC; Bhambhvani, P; Hage, FG; McConathy, JE | 1 |
| Akdemir, ÜÖ; Ataş, N; Atay, LÖ; Aydos, U; Babaoglu, H; Bilici Salman, R; Göker, B; Gülbahar Ateş, S; Güler, AA; Haznedaroğlu, Ş; Karadeniz, H; Öztürk, MA; Satiş, H; Tufan, A; Yapar, D | 1 |
| Yang, MF | 1 |
| Chen, L; Jin, Y; Li, S; Liao, J; Liu, C; Lu, W; Tang, R; Wang, J; Wang, T | 1 |
| Al-Zaghal, A; Alavi, A; Arani, LS; Baker, JF; Gerke, O; Hunt, SJ; Høilund-Carlsen, PF; Raynor, WY; Revheim, ME; Rojulpote, C; Seraj, SM; Werner, TJ; Zadeh, MZ | 1 |
| Hasse, B; Huellner, MW; Husmann, L | 1 |
| Gomez, MF; Hellberg, S; Huusko, J; Knuuti, J; Liljenbäck, H; Nuutila, P; Roivainen, A; Saraste, A; Silvola, JMU; Söderström, M; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
| Chamroonrat, W | 1 |
| Al-Mallah, MH; Hyafil, F; Santulli, G | 1 |
| Berthier, F; Chironi, G; Claessens, YE; Dietz, M; Faraggi, M; Farhad, RL; Giammarile, F; Hugonnet, F; Keita-Perse, O; Nataf, V; Paulmier, B; Perrin, C; Rouquette, I; Serrano, B | 1 |
| Agaimy, A; Agarwal, R; Atzinger, A; Baeuerle, T; Bergmann, C; Cordes, M; Distler, JHW; Götz, TI; Haberkorn, U; Hennig, P; Kleyer, A; Köhner, M; Kuwert, T; Manger, B; Maschauer, S; Prante, O; Ramming, A; Rauber, S; Ritt, P; Schett, G; Schmidkonz, C; Soare, A; Stone, JH; Toms, J | 1 |
| Ćorović, A; Mason, JC; Rudd, JHF; Tarkin, JM; Wall, C | 1 |
| Auwaerter, PG; Dibble, EH; Mackowiak, PA; Rowe, SP; Wright, WF | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Branton, WG; Doan, MAL; Fernandes, JP; Major, EO; Monaco, MC; Power, C; Saito, LB; Schmitt, LM; Smith, MJ; Wuest, F; Wuest, M | 1 |
| Kamiya, T; Murakami, S; Naka, S; Shimamoto, H; Watabe, T | 1 |
| Joung, C; Kim, EJ; Kim, S; Pahk, K; Seo, HS | 1 |
| Jain, D | 1 |
| Aigner, R; Arefnia, B; Brodmann, M; Gasser, R; Gütl, K; Horina, A; Kerschbaumer, S; Kulnik, R; Mangge, H; Muster, V; Quehenberger, F; Seinost, G; Wimmer, G; Zelzer, S | 1 |
| Consul, N; Namireddy, MK; Sher, AC | 1 |
| Dey, A; Manyak, G; Mehta, NN; Patel, N; Teague, H; Teklu, M; Zhou, W | 1 |
| Baumann, M; Kotzerke, J; Krause, M; Löck, S; Seidlitz, A; Troost, EGC; Zips, D; Zöphel, K; Zschaeck, S | 1 |
| Abbass, T; Buali, F; Colville, D; Dolan, RD; Horgan, PG; Maclay, JD; MacLeod, N; McMillan, DC; McSorley, ST | 1 |
| Chacko, AM; Chan, KWK; Kalimuddin, S; Low, JG; Sam, H; Tham, JY; Totman, JJ; Vasudevan, SG; Watanabe, S; Xie, W; Yap, TS | 1 |
| Kuang, A; Shen, G | 1 |
| Ahlman, MA; Dashora, H; Grayson, PC; Novakovich, E; Quinn, KA | 1 |
| Asami, T; Dam, TT; Kim, M; Kurihara, J; Ogawa, M; Shimizu, T; Suzuki, K; Yamaguchi, T; Yokoo, S | 1 |
| Isobe, M; Maejima, Y; Saji, M; Tateishi, U | 1 |
| Dweck, MR | 1 |
| Butler, J; Kovacs, M; Prato, FS; Smailovic, H; Sykes, J; Thiessen, JD; Wilk, B; Wisenberg, G | 1 |
| Bakhshi, SK; Hasnain, N; Mustafa, RM; Shamim, MS | 1 |
| Becker, C; Gørtz, PM; Hansen, PR; Henningsen, KMA; Kaiser, H; Krakauer, M; Kvist-Hansen, A; Skov, L; Wang, X | 1 |
| Advani, RH; Doan, BH; Iagaru, A; Jarr, KU; Kojima, Y; Leeper, NJ; Nakamoto, R; Weissman, IL | 1 |
| Hoogeveen, RM; Kaiser, Y; Kroon, J; Moens, SJB; Stroes, ESG; Verberne, HJ; Verweij, SL; Vogt, L | 1 |
| Liesker, DJ; Mulder, DJ; Saleem, BR | 1 |
| Cheyne, L; Dawson, DK; Delibegovic, M; Godsman, N; Hepburn, C; Kohlhaas, M; Maack, C; Mingarelli, M; Munts, C; Nickel, A; Schweiger, L; Van Bilsen, M; Welch, A | 1 |
| Agca, R; Blanken, AB; Boellaard, R; Nurmohamed, MT; Smulders, YM; van der Laken, CJ; van Sijl, AM; Voskuyl, AE | 1 |
| Kuang, A; Shen, G; Wang, R | 1 |
| Dilsizian, V; Palestro, CJ; Wahl, RL | 1 |
| Fayad, ZA; Giannarelli, C; Jacobi, A; Mani, V; Naidu, S; Sahota, A; Woodward, M | 1 |
| Mayadev, J; Williamson, CW; Zamarin, D | 1 |
| Chen, CC; Chuang, CY; Li, C; Lin, JW; Yeh, HL | 1 |
| Iwata, M; Terasawa, T; Toyama, H; Tsuzuki, S; Watanabe, A | 1 |
| Al-Kindi, SG; Avery, A; Chami, T; Hajjari, J; Hileman, CO; Janus, SE; Labbato, D; McComsey, GA; Smith, C; Sullivan, C | 1 |
| Fan, Q; Su, M; Tian, R; Wang, R | 1 |
| Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH | 1 |
| Ćorović, A; Mallat, Z; Nus, M; Rudd, JHF; Tarkin, JM | 1 |
| Glaudemans, AWJM; Gormsen, LC; Kwee, TC; Nienhuis, PH; Pijl, JP; Slart, RHJA | 1 |
| Celiker-Guler, E; Ruddy, TD; Wells, RG | 1 |
| Kuriyama, K; Nakazawa, N; Ogawa, H; Saeki, H; Saito, H; Sakai, M; Sano, A; Shirabe, K; Sohda, M; Ubukata, Y; Uchida, S; Watanabe, T; Yamaguchi, A; Yokobori, T | 1 |
| Chikuda, H; Nakajima, T; Okamura, K; Sakane, H; Suto, T; Trang, DAMT; Tsushima, Y; Yonemoto, Y | 1 |
| Civelek, AC; He, ZX; Li, XF; Li, YM; Yao, Y | 1 |
| Aikawa, NE; Astley, C; Buchpiguel, CA; Campos, LMA; Carneiro, CG; Clemente, G; de Sá Pinto, AL; Gil, S; Gualano, B; Leão Filho, H; Lima, MS; Pereira, RMR; Roschel, H; Silva, CA; Terreri, MT | 1 |
| Burschtin, O; Cohen, O; Fayad, Z; John, MM; Kaufman, AE; Khan, S; Kundel, V; Mani, V; Shah, NA | 1 |
| Narula, J; Strauss, HW | 1 |
| Hunter, HJA | 1 |
| Hellberg, S; Jauhiainen, M; Knuuti, J; Liljenbäck, H; Metso, J; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Savisto, N; Silvola, JMU; Sippola, S; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
| Aberra, TM; Ahlman, MA; Baumer, Y; Chaturvedi, A; Chung, JH; Dey, AK; Ehrlich, A; Gelfand, JM; Gerson, E; Green, LJ; Harrington, CL; Joshi, AA; Kabbany, MT; Lerman, JB; Lockshin, BN; Mehta, NN; Natarajan, B; Ng, Q; Playford, MP; Prussick, RB; Rivers, JP; Rodante, JA; Sanda, GE; Silverman, JI; Sorokin, AV; Teague, HL | 1 |
| Kim, JB; Kim, JW; Lee, S; Nam, HS; Oh, DJ; Park, EJ; Yoo, H | 1 |
| Haarala, A; Kähönen, M; Korkola, P; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H | 1 |
| Gerard, P; Harikrishnan, P; Jain, D | 1 |
| Fu, Z; Li, Q; Li, Z; Liu, M; Zhang, J | 1 |
| Gormsen, LC; Hjuler, KF; Iversen, L | 1 |
| Kouranos, V; Wechalekar, K | 1 |
| Aguilar Suárez, R; Boersma, HH; de Jong, JR; Elsinga, PH; Glaudemans, AWJM; Heuker, M; Luurtsema, G; Sijbesma, JWA; Slart, RHJA; van Dam, GM; van Dijl, JM; van Oosten, M | 1 |
| Albert, N; Bartenstein, P; Blume, T; Brendel, M; Deussing, M; Focke, C; Haass, C; Herms, J; Jaworska, A; Kleinberger, G; Lindner, S; Overhoff, F; Peters, F; Probst, F; Rominger, A; von Ungern-Sternberg, B | 1 |
| Chen, J; Geng, Q; Hou, Q; Huang, W; Liu, Y; Luo, J; Nie, Z; Xie, N; Yang, F; Zhou, Y | 1 |
| Boellaard, R; Comans, EFI; Heymans, MW; Lensen, KDF; Nurmohamed, MT; Smulders, YM; van der Laken, CJ; van Sijl, AM; Voskuyl, AE | 1 |
| Ishikawa, T; Kitamura, K; Nagamachi, S; Sakamoto, S; Tsuruda, T; Yamaguchi, M | 1 |
| Nishiyama, Y; Noma, T; Norikane, T; Yamamoto, Y | 1 |
| Asa, S; Cicik, E; Kabasakal, L; Sağer, S; Sönmezoğlu, K; Uslu-Beşli, L | 1 |
| Boursot, C; Coindre, JP; Hachemi, M; Molfino, I; Piccoli, GB | 1 |
| Ehrlichmann, W; Feil, R; Feil, S; Gawaz, M; Golla, M; Griessinger, CM; Kneilling, M; Kohlhofer, U; Lang, F; Langer, HF; Lin, Y; Olbrich, M; Pichler, BJ; Quintanilla-Martinez, L; Reischl, G; Schäfers, M; Schörg, BF; Thunemann, M; Vachaviolos, A; Voelkl, J | 1 |
| Chandrashekhar, Y; Dilsizian, V | 1 |
| Kiko, T; Masuda, A; Nemoto, A; Oriuchi, N; Takeishi, Y; Tominaga, H; Yoshihisa, A | 1 |
| Feng, T; Li, J; Nie, M; Xu, J; Xu, Z; Yan, Y; Zhang, M; Zhao, Q; Zhao, X | 1 |
| Aslam, F | 1 |
| Bredemeier, M | 1 |
| Choi, IH; Kim, HJ; Kim, SY; Lee, R; Lee, SM; Lkhamsuren, K; Park, IH; Park, YN; Shin, JS; Son, M; Song, JH; Yoo, KH | 1 |
| Blankstein, R; Donal, E; Dorbala, S; Gheysens, O; Gimelli, A; Glaudemans, AWJM; Hacker, M; Hyafil, F; Jaber, WA; Lancellotti, P; Miller, EJ; Plein, S; Rouzet, F; Russell, R; Schwartz, RG; Slart, RHJA | 1 |
| Galuska, L; Garai, I; Kacska, S; Lovas, S; Palatka, K; Varga, J | 1 |
| Pacher, P; Schindler, TH | 1 |
| Ito, H; Nara, I; Sato, W; Watanabe, H | 1 |
| Avni-Biron, I; Ben-Bassat, O; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Leibovitzh, H; Lichtenstein, L; Nidam, M | 1 |
| Haarala, A; Kähönen, M; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H | 1 |
| Cachin, F; Descamps, L; Mathieu, S; Merlin, C; Olagne, L; Soubrier, M | 1 |
| Schett, G; Schönau, V | 2 |
| Tavakoli, S | 1 |
| Colville, D; Han, S; Horgan, PG; Khor, BY; McMillan, DC; McSorley, ST; Tsang, K | 1 |
| Falanga, A; Gauchotte, G; Groubatch, F; Liu, Y; Marie, PY; Marie, V; Maureira, P; Poussier, S; Tran, N; Yang, X | 1 |
| Amigues, I; Bathon, JM; Bokhari, S; Giles, JT; Morgenstern, R | 1 |
| Armagan, B; Beydas, O; Erden, A; Kalyoncu, U; Kilic, L; Sari, A | 1 |
| Dantes, M; Eze, C; Manapov, F; Pazos-Escudero, M; Roengvoraphoj, O | 1 |
| Anzola, KL; Auletta, S; Galli, F; Lauri, C; Pacilio, M; Petitti, A; Signore, A; Varani, M | 1 |
| Fernández-Ruiz, I | 1 |
| Beiderwellen, K; Dobos, G; Grüneisen, J; Herrmann, K; Langhorst, J; Lauenstein, T; Li, Y; Nensa, F; Umutlu, L | 1 |
| Chin, FT; Mahmoudi, M; McConnell, MV; Saito, T; Tuerkcan, S; Xing, L; Yang, PC; Zaman, RT | 1 |
| Andrews, JPM; Dweck, MR; Fayad, ZA | 1 |
| Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Nakamura, T; Suda, K; Sugiyama, Y; Sun, J; Tahara, A; Tahara, N; Tanaka, H | 1 |
| Chen, W; Dilsizian, V; Sajadi, MM | 1 |
| Hyafil, F; Vigne, J | 1 |
| Fukuzawa, K; Hirata, KI; Kiuchi, K; Mori, S; Watanabe, Y | 1 |
| Erba, PA; Signore, A | 1 |
| Bengel, FM; Ross, TL | 1 |
| Chang, K; Chu, EH; Han, EJ; Hwang, BH; Kim, CJ; Kim, JJ; Kim, SH; O, JH; Seung, KB | 1 |
| Low, AHL; Marchesseau, S; Ng, DC; Ng, SA; Totman, JJ; Wang, YT; Xie, W | 1 |
| Kumar, R; Mittal, BR; Parihar, AS; Rana, S; Singh, H; Singh, S; Vadi, SK | 1 |
| Hashimoto, S; Motta-Ribeiro, G; Vidal Melo, MF; Winkler, T | 1 |
| Bogsrud, TV; Ejlersen, JA; Gormsen, LC; Hansen, IT; Haraldsen, A; Hauge, EM; Hjorthaug, K; Keller, KK; Kramer, S; Nielsen, BD; Stolle, LB; Therkildsen, P | 1 |
| Akioka, N; Kashiwazaki, D; Kuroda, S; Kuwayama, N; Noguchi, K; Yamamoto, S | 1 |
| Bauer, J; Ergün, S; Hayakawa, N; Higuchi, T; Jahns, R; Jahns, V; Javadi, MS; Lapa, C; Schütz, C; Wakabayashi, H; Werner, RA; Zechmeister, C | 1 |
| Boutley, H; Clément, A; Karcher, G; Kolodziej, A; Lhuillier, M; Marie, PY; Maskali, F; Olivier, JL; Pierson, J; Poussier, S | 1 |
| Pelletier-Galarneau, M; Ruddy, TD | 2 |
| Kan, Y; Liu, J; Wang, W; Wang, Z; Yang, J | 1 |
| Aberra, TM; Ahlman, MA; Baumer, Y; Belur, AD; Bluemke, DA; Chen, MY; Chung, J; Dave, J; Dey, AK; Elnabawi, YA; Gelfand, JM; Goyal, A; Groenendyk, JW; Joshi, AA; Lerman, JB; Mehta, NN; Natarajan, B; Playford, MP; Rivers, JP; Rodante, JA; Sajja, AP; Salahuddin, T; Teague, HL | 1 |
| Choi, KM; Lee, YB | 1 |
| Bermudez, S; Byrnes, KR; Dardzinski, BJ; Jaiswal, S; Moritz, KE; von Leden, RE; Wilson, CM | 1 |
| Blankstein, R; Bravo, PE; Di Carli, MF; Singh, A | 1 |
| Campaniello, MA; Dmochowska, N; Hughes, PA; Keller, MD; Mavrangelos, C; Takhar, P; Tieu, W; Wardill, HR | 1 |
| Alavi, A; Basu, S; Jahangiri, P; Pawaskar, A | 1 |
| Bokhari, S; Flaherty, KR; Flores, RJ; Jin, Z | 1 |
| Abe, T; Fujimoto, K; Fukumoto, Y; Kurata, S; Saku, K; Shintani, Y; Shojima, T; Tahara, N; Takagi, K; Takaseya, T; Tanaka, H | 1 |
| Ha, ND; Jo, JC; Park, SH; Seo, M | 1 |
| Masdeu, JC; Pascual, B; Rostomily, RC; Turkheimer, F; Veronese, M; Zanotti-Fregonara, P | 1 |
| Abikhzer, G; Hudson, M; Maliha, PG; Probst, S; Singerman, J | 1 |
| Benali, K; Chequer, R; Hyafil, F; Le Guludec, D; Mahida, B; Mikail, N; Piekarski, E; Rouzet, F; Sinigaglia, M | 1 |
| Alavi, A; Carlin, S; Cheon, GJ; Chung, JK; Kang, KW; Kim, MJ; Kwon, J; Lee, CH; Lee, Y; Youn, H | 1 |
| Abdelmessih, M; Baldassarre, LA; Miller, EJ; Rosenfeld, LE; Sharp, MB; Soufer, A | 1 |
| Busch, M; Drescher, R; Freesmeyer, M; Gühne, F; Seifert, P | 1 |
| Ding, J; Du, W; Kang, F; Li, X; Li, Y; Li, Z; Pang, L; Wu, Z; Zhao, Y; Zheng, Z; Zhu, P | 1 |
| Bekki, M; Fukumoto, Y; Hirakata, S; Honda, A; Igata, S; Ito, S; Kaieda, S; Kuromatsu, R; Maeda-Ogata, S; Nakashima, O; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
| Barsalou, J; Decaluwe, H; Décarie, JC; Haddad, E; Lambert, R; Levasseur, MA; Martineau, P; Meijer, I; Renaud, C; Turpin, S | 1 |
| Arai-Okuda, H; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
| Bhatt, DL; Blankstein, R; Libby, P | 1 |
| Cosgrove, KP; Emami, H; Esterlis, I; Han, J; Hillmer, AT; Liu, C; Peters, D; Sadeghi, MM; Toczek, J; Wu, J | 1 |
| Jaber, WA; Schenone, AL | 1 |
| Domschke, K; Hellwig, S; Meyer, PT | 1 |
| Corbett, JR; Ficaro, EP; Hulten, EA; Larson, SR; Murthy, VL; Pieper, JA; Weinberg, RL | 1 |
| Croteau, E; Levasseur, MA; Marcotte, ME; Panet, F; Pavic, M; Richard, MA | 1 |
| Gross, MD; Manganaro, MS; Rahman, WT; Rubello, D; Townsend, DM; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
| Can, C; Komek, H | 1 |
| Loock, J; Manger, B | 1 |
| Du, Y; Guo, J; Hao, G; Mohan, C; Oz, OK; Sun, X; Zhou, XJ | 1 |
| Artiko, VM; Grozdic, IT; Obradovic, VB; Pavlovic, SV; Saranovic, DZ; Sobic-Saranovic, DP; Videnovic-Ivanov, J; Vucinic-Mihailovic, V | 1 |
| Buscombe, J | 2 |
| Ballet, S; Bini, J; Corot, C; Dickson, SD; Fayad, ZA; Izquierdo-Garcia, D; Klink, A; Lancelot, E; Mateo de Castro, J; Millon, A; Robert, P | 1 |
| Chen, W; Dilsizian, V | 3 |
| Chander, A; Nash, J; Rees, J; Sanchez-Roa, P | 1 |
| Hirata, K; Houkin, K; Kuroda, S; Magota, K; Nakayama, N; Saito, H; Shiga, T; Tamaki, N; Terae, S; Yoshida, D | 1 |
| C Gaertner, F; Manabe, O; Masuda, A; Matsushima, S; Naya, M; Oyama-Manabe, N; Tamaki, N; Tsutsui, H; Yamada, S | 1 |
| Akers, SR; Alavi, A; Cheng, G; Del Bello, CV | 1 |
| Hladká, H; Rehák, Z; Stanícek, J; Szturz, P; Vanícek, J | 1 |
| El-Chemaly, S; Gahl, WA; Gochuico, BR; Malide, D; Moss, J; Nathan, SD; Rosas, IO; Yao, J | 1 |
| Abdelbaky, A; Alon, A; Beals, CR; Dansky, H; Farkouh, ME; Fayad, ZA; Klimas, MT; Mogg, R; Nunes, IO; Rudd, JH; Shankar, SS; Subramanian, SS; Tawakol, A | 1 |
| Rao, L; Shen, B; Wang, X; Yang, Z; Zhang, X | 1 |
| Akers, SR; Alavi, A; Blomberg, BA; Cheng, G; Del Bello, C; Lim, E; Mehta, NN; Saboury, B; Torigian, DA; Werner, TJ | 1 |
| Bélanger, MJ; Connolly, BM; Guenther, I; Kularatne, SA; Low, PS; McQuade, P; Meng, X; Suresch, DL; Trotter, DG; Vanko, A; Wang, S | 1 |
| Daemen, MJ; Marsch, E; Sluimer, JC | 1 |
| Chen, HJ; Cheng, LQ; Gai, JJ; Li, J; Liu, HB; Liu, JJ; Wang, Y; Xie, LX; Yin, DY; Zhang, XW; Zhao, XH | 1 |
| de Vries, EF; Dierckx, RA; Galli, F; Glaudemans, AW; Signore, A; Slart, RH | 1 |
| de Prost, N; Harris, RS; Kradin, RL; Musch, G; Venegas, JG; Vidal Melo, MF; Wellman, TJ; Winkler, T | 1 |
| Daimon, M; Funabashi, N; Kobayashi, Y; Ozawa, K; Takano, H; Takaoka, H; Uehara, M | 1 |
| Abdulla, S; Alavi, A; Basu, S; Saboury, B; Salavati, A; Torigian, DA | 1 |
| Artiko, V; Obradovic, V; Sobic-Saranovic, D | 1 |
| Backes, WH; Bucerius, J; Daemen, MJ; Hermeling, E; Kooi, ME; Kwee, RM; Mess, WH; Truijman, MT; van Hoof, RH; van Oostenbrugge, RJ; Wildberger, JE | 1 |
| Imaizumi, T; Narula, J; Tahara, A; Tahara, N | 1 |
| Goodman, MM; Kawai, K; Oka, S; Okudaira, H; Ono, M; Schuster, DM; Shirakami, Y | 1 |
| Bengel, FM; Schatka, I | 1 |
| Bucerius, J; Farkouh, ME; Fayad, ZA; Fuster, V; Machac, J; Mani, V; Moncrieff, C; Rudd, JH; Tawakol, A | 1 |
| Gersak, B; Jezovnik, MK; Lezaic, L; Poredos, P; Zidar, N | 1 |
| Cetiner, M; Demirkol, O; Ergonul, O; Ferhanoglu, B; Tokmak, H | 1 |
| Bittencourt, MS; Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Hulten, EA; Murthy, VL; Osborne, MT; Singh, A; Skali, H; Stewart, GC; Waller, AH | 1 |
| Bucerius, J; Farkouh, ME; Fayad, ZA; Fuster, V; Izquierdo-Garcia, D; Machac, J; Mani, V; Moncrieff, C; Rudd, JH; Wong, S | 1 |
| Amato, M; Borges, JB; Costa, EL; Hedenstierna, G; Larsson, A; Suarez-Sipmann, F; Widström, C | 1 |
| Abt, M; Bucerius, J; Fayad, ZA; Kallend, D; Mani, V; Rudd, JH; Samber, D; Tawakol, A; Woodward, M | 1 |
| Akyuz, F; Degirmenci, I; Entok, E; Gunes, HV; Kurt, H; Ozbayer, C; Tekin, N; Ustuner, MC; Yangi, B | 1 |
| Feng, TT; Su, G; Zhang, MD; Zhang, XX; Zhao, QM; Zhao, X; Zhao, XC; Zhuang, XC | 1 |
| Burgess, N; Critchley, HD; Doeller, CF; Harrison, NA; Voon, V | 1 |
| Fanti, S; Lovato, L; Nanni, C; Rapezzi, C; Saia, F; Taglieri, N | 1 |
| Chen, X; Kiesewetter, DO; Niu, G; Teng, G; Wang, Y; Yue, X | 1 |
| Ametamey, SM; Beck, K; Betzel, T; Fischer, CR; Kaufmann, PA; Krämer, SD; Müller, A; Müller, C; Rancic, Z; Schibli, R | 1 |
| Filipiak, K; Kiliszek, M; Kobylecka, M; Kochman, J; Królicki, L; Mazurek, T; Opolski, G; Skubisz-Głuchowska, J | 1 |
| Balink, H; Bennink, RJ; van Eck-Smit, BL; Veeger, NJ; Verberne, HJ | 1 |
| Hermann, S; Jacobs, AH; Kloth, C; Kuhlmann, MT; Schäfers, MA; Schober, O; Wenning, C | 1 |
| Akijian, L; Barry, M; Chróinín, DN; Crowe, M; Dolan, E; Fallon, E; Horgan, G; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K | 1 |
| Hu, K; Huang, T; Liang, X; Nie, D; Sun, T; Tang, G; Tang, X; Wang, H | 1 |
| Costa, EL; Harris, RS; Musch, G; Venegas, JG; Vidal Melo, MF; Wellman, TJ; Winkler, T; Zheng, H | 1 |
| Dubner, Y; Goldin, E; Koslowsky, B; Lalazar, G; Mahamid, M; Shteingart, S; Wengrower, D | 1 |
| Chen, H; Guan, Z; Han, X; Liang, C; Liu, H; Sun, J; Wang, J; Wei, L; Xie, L; Xue, H; Yu, S; Yuan, C; Zhao, X | 1 |
| Belaj, K; Brodmann, M; Gary, T; Hackl, G; Hafner, F; Lipp, RW; Milosavljevic, R; Rief, P | 1 |
| Devillers, A; Michelet, C; Patrat-Delon, S; Revest, M; Tattevin, P | 1 |
| Caobelli, F | 1 |
| Hirokawa, T; Matsuo, Y; Morimoto, M; Sato, M; Sato, T; Shamoto, T; Shibata, T; Takahashi, H; Takeyama, H; Tsuboi, K | 1 |
| Joshi, FR; Rudd, JH; Tarkin, JM | 1 |
| Drenth, JP; Gevers, TJ; Lantinga, MA | 1 |
| Broussolle, C; Hot, A; Iwaz, J; Maucort-Boulch, D; Robine, A; Sève, P | 1 |
| Baccega, M; Conrotto, F; D'Ascenzo, F; De Berardinis, A; Fava, A; Grasso, C; Lesca, A; Marra, S; Sbarra, P | 1 |
| Bernards, N; Boisgard, R; Dollé, F; Pottier, G; Thézé, B | 1 |
| Choe, H; Ike, H; Inaba, Y; Kobayashi, N; Miyamae, Y; Saito, T; Yukizawa, Y | 1 |
| Bauersachs, J; Bengel, FM; Berding, G; Brunkhorst, T; Roentgen, P; Schäfer, A; Schatka, I; Wollenweber, T; Zwadlo, C | 1 |
| Cauchon, N; Hasséssian, HM; Lecomte, R; Turcotte, E; van Lier, JE | 1 |
| Bol, A; Demeure, F; Gerber, B; Hanin, FX; Jamar, F; Pasquet, A; Pouleur, AC; Vancraeynest, D; Vanoverschelde, JL; Vincent, MF | 1 |
| Bankstahl, JP; Bengel, FM; Korf-Klingebiel, M; Thackeray, JT; Walte, A; Wang, Y; Wittneben, A; Wollert, KC | 1 |
| Belkin, M; Di Carli, MF; Folco, EJ; Jerosch-Herold, M; Kwong, RY; Libby, P; Murthy, VL; Nahrendorf, M; Ozaki, CK; Sukhova, GK; Taqueti, VR; Weissleder, R | 1 |
| Avni, T; Bernstine, H; Gafter-Gvili, A; Groshar, D; Grossman, A; Leibovici, L; Paul, M; Raibman, S; Tadmor, B | 1 |
| Mortensen, MB | 1 |
| Nahrendorf, M; Swirski, FK | 1 |
| Camellino, D; Cimmino, MA; Massollo, M; Paparo, F; Piccardo, A; Puppo, C; Rollandi, GA; Shoushtari Zadeh Naseri, M; Villavecchia, G | 1 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Emami, H; Fayad, ZA; Figueroa, A; Hemphill, LC; Hovingh, GK; Kastelein, JJ; Koopman, MG; Lobatto, ME; MacNabb, MH; Mulder, WJ; Schulte, DM; Sjouke, B; Stroes, ES; Tawakol, A; van der Valk, FM; van Wijk, DF; Verberne, HJ | 1 |
| Chao, W; Costa, EL; de Prost, N; Feng, Y; Harris, RS; Musch, G; Tucci, MR; Venegas, JG; Vidal Melo, MF; Wellman, T; Winkler, T | 1 |
| Chen, F; Chen, J; Cheng, H; Dong, Q; Huang, Z; Pan, D; Xiong, W; Zhang, Y | 1 |
| Bankstahl, JP; Bengel, FM; Thackeray, JT; Wang, Y; Wollert, KC | 1 |
| Cheong, SJ; Jeong, HJ; Kim, EM; Lee, CM; Lim, ST; Sohn, MH | 1 |
| Kang, DW; Kim, HJ; Kim, JS; Kwon, SU; Moon, DH; Oh, M; Yu, KH | 1 |
| Abgral, R; Couturaud, F; Delluc, A; Le Gal, G; Le Roux, PY; Reffad, A; Robin, P; Salaun, PY; Tardy, B | 1 |
| Fukumoto, Y; Honda, A; Igata, S; Ishibashi, M; Kaida, H; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S | 1 |
| Abe, T; Fukumoto, Y; Honda, A; Kaida, H; Kishimoto, S; Kudo, Y; Suda, K; Tahara, N; Ueno, T; Yoshimoto, H | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Tsushima, Y; Yokoo, H; Yokoo, S | 1 |
| Acevedo-Báñez, I; Borrego-Dorado, I; García-Gómez, FJ; García-Gutiérrez, M; Martínez-Castillo, R; Tirado-Hospital, JL | 1 |
| Liu, Y; Tian, X; Wang, H; Zhang, W; Zhu, Z | 1 |
| Abdelbaky, A; Corsini, E; Emami, H; Figueroa, AL; Fontanez, S; Hoffmann, U; Narula, J; Subramanian, S; Tawakol, A | 1 |
| Raggi, P | 1 |
| Blackwood, KJ; Butler, J; Keenliside, L; Mikami, Y; Prato, FS; Sykes, J; Thiessen, JD; Thompson, RT; White, JA; Wisenberg, G | 1 |
| Aoki, M; Arai, A; Fujihara, K; Kaneta, T; Misu, T; Tateyama, M | 1 |
| Evensen, K; Fjeld, JG; Johnsrud, K; Krohg-Sørensen, K; Reier-Nilsen, F; Revheim, ME; Russell, D; Scott, H; Skagen, K; Skjelland, M | 1 |
| Alchalby, H; Apostolova, I; Bannas, P; Bengel, FM; Derlin, T; Kröger, N; Triviai, I; Veldhoen, S | 1 |
| Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM | 1 |
| Ding, D | 1 |
| Anderson, CM; Buatti, JM; Button, A; Chang, T; Graham, MM; Marquardt, MD; Menda, Y; Pagedar, NA; Smith, BJ; Sun, W | 1 |
| Brouwer, E; Comans, EF; Glaudemans, AW; Lensen, KD; Pereira Arias-Bouda, LM; Slart, RH; Smulders, YM; van der Laken, CJ; Voskuyl, AE; Zwijnenburg, AT | 1 |
| Alavi, A; deGoma, EM; Dunbar, RL; Litt, HI; Mehta, NN; Mohler, ER; Pollan, L; Rader, DJ; Saboury, B; Salavati, A; Schoen, M; Shinohara, RT; Torigian, DA; Woo, J | 1 |
| Burg, S; Buvat, I; Huet, P; Hyafil, F; Le Guludec, D | 1 |
| Balink, H; Bennink, RJ; Holleman, F; Slart, RH; van Eck-Smit, BL; Veeger, NJ; Verberne, HJ | 1 |
| Fukao, K; Hamada, T; Kubo, N; Kuge, Y; Nakano, T; Shimizu, Y; Tamaki, N; Ukon, N; Watanabe, A; Yamasaki, K; Zhao, S; Zhao, Y | 1 |
| Lv, SZ; Wang, ZM; Yan, YF; Zhang, MD; Zhang, YH; Zhao, QM; Zhao, XC | 1 |
| Alavi, A; Gholami, S; Houshmand, S; Salavati, A; Werner, TJ | 1 |
| Paliwal, PR; Sharma, VK; Sinha, AK | 1 |
| Abdelbaky, A; Ballantyne, CM; Du, S; Ehlgen, A; Emami, H; Farkouh, ME; Farmer, M; Fayad, ZA; Hayes, W; Kim, J; Langenickel, TH; Li, L; Mohler, ER; Roth, E; Subramanian, S; Tawakol, A; Velasquez, L; Vucic, E | 1 |
| Chowdhury, FU; Patel, CN; Scarsbrook, AF; Vaidyanathan, S | 1 |
| Claessen, AM; Crommelin, HA; Deneer, VH; Grutters, JC; Keijsers, RG; Meek, B; van Moorsel, CH; Vorselaars, AD | 1 |
| Del Sole, A; Lecchi, M; Lucignani, G | 1 |
| Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT | 1 |
| Basu, S; Ranade, R | 1 |
| Asami, Y; Hama, M; Ihata, A; Ishigatsubo, Y; Kamiyama, R; Kirino, Y; Kishimoto, D; Kunishita, Y; Ohno, S; Suda, A; Takase-Minegishi, K; Takeno, M; Tateishi, U; Ueda, A; Watanabe, T; Yoshimi, R | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Hong, HC; Hwang, SY; Kim, NH; Kim, S; Kim, SG; Park, S; Ryu, JY; Seo, JA; Yoo, HJ | 1 |
| Ajijola, O; Auerbach, M; Barrio, M; Bauer, B; Bradfield, J; Chan, S; Ferris, J; Gupta, P; Lynch, JP; Schelbert, H; Schiepers, C; Shivkumar, K; Tung, R | 1 |
| Alessio, AM; Caldwell, JH; Ferguson, MS; Hatsukami, TS; Hippe, DS; Kerwin, WS; Kohler, TR; Liu, J; Martinez-Malo, V; Miyaoka, RS; Pimentel, K; Yuan, C | 1 |
| Choi, CU; Kim, JB; Kim, JW; Kim, S; Lee, S; Lim, HE; Na, JO; Oh, DJ; Park, CG; Rha, SW; Yoo, H | 1 |
| Fujita, K; Kida, H; Kusumi, F; Miyajima, S; Morisawa, T; Ohana, M; Okano, A; Okinaga, S; Omura, A; Takai, R | 1 |
| Chowdhury, FU | 1 |
| Chen, K; Hai, W; Huang, Q; Peng, J; Xu, Y; Yang, Z; Zan, Y; Zheng, X | 1 |
| Glaudemans, AW; Israel, O; Slart, RH | 1 |
| Hara, T; Ito, H; Kubo, H; Masuda, A; Niitsuma, T; Takeishi, Y; Takenoshita, S; Wada, K; Yamaki, T | 1 |
| Doruyter, A; Sathekge, M; Vorster, M; Warwick, JM | 1 |
| Budde, RP; Lam, MG; Scholtens, AM; Verberne, HJ | 1 |
| Hu, K; Huang, T; Li, S; Liang, X; Tang, G; Wang, H; Wu, Z | 1 |
| Bala, G; Blykers, A; Broisat, A; Caveliers, V; Cosyns, B; Descamps, B; Devoogdt, N; Droogmans, S; Fagret, D; Ghezzi, C; Hernot, S; Lahoutte, T; Van Camp, G; Vanhove, C; Xavier, C | 1 |
| Chrapko, BE; Chrapko, M; Drop, A; Nocuń, A; Stefaniak, B; Zubilewicz, T | 1 |
| Choe, JG; Kim, S; Pahk, K; Rhee, S | 1 |
| Abourbeh, G; Betzer, O; Dreifuss, T; Mishani, E; Motiei, M; Panet, H; Popovtzer, A; Popovtzer, R; Santana, J | 1 |
| Barré, L; Dhilly, M; Guillouet, S; Hovhannisyan, N; Leporrier, M | 1 |
| Bhambhvani, P | 1 |
| Katabathina, VS; Khalil, S; Lath, N; Menias, CO; Prasad, SR; Shin, S | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yang, Z; Yi, C; Zhang, X; Zong, Z | 1 |
| Ishihara, K; Kiriyama, T; Kobayashi, Y; Kumita, SI; Onoguchi, M; Sakurai, M; Shibutani, T; Suda, M | 1 |
| Jezovnik, MK; Lezaic, L; Mijovski, MB; Poredos, P; Spirkoska, A | 1 |
| Kim, BI; Kim, JY; Kim, KM; Lee, JW; Lee, KC; Lee, YJ; Park, JA; Shin, UC; Yoo, RJ | 1 |
| Ruddy, TD; Wells, RG | 1 |
| Chowdhury, MM; Evans, NR; Rudd, JH; Sriranjan, RS; Tarkin, JM | 1 |
| Alam, MS; Guan, W; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Bucerius, J | 1 |
| Faust, A; Hermann, S; Honold, L; Schäfers, M; Vrachimis, A | 1 |
| Ahn, JM; Chang, M; Kang, SJ; Kim, YH; Lee, CW; Lee, HS; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW | 1 |
| Alexanderson-Rosas, E; Estrada, E; Garcia-Pérez, O; Juarez-Orozco, LE; Martinez-Aguilar, MM; Monroy-Gonzalez, AG; Soldevilla, I; Soto-Lopez, ME | 1 |
| Lawal, I; Sathekge, M | 1 |
| Kubo, H; Kunii, H; Masuda, A; Nemoto, A; Oriuchi, N; Takeishi, Y; Takenoshita, S; Tominaga, H; Yamaki, T | 1 |
| Fernandez, P; Meyer, M; Zanotti-Fregonara, P | 1 |
| Asmis, R; Downs, K; Goins, B; Jerabek, P; Lai, Y; Nguyen, HN; Sadeghi, MM; Short, JD; Tavakoli, S; Zhang, W | 1 |
| Han, Y; Li, DC; Liu, SM; Wang, ZG; Wu, FY; Yang, GJ; Yu, MM | 1 |
| Mehta, NN | 1 |
| Afshar, SF; Gaber, MW; Kaffes, CK; Rendon, DA; Sabek, OM; Tang, TT; Zawaski, JA | 1 |
| Ali, A; Calcagno, C; Fayad, ZA; Figueroa, AL; Hoffmann, U; Ishai, A; Kaiser, Y; Mani, V; Mulder, WJ; Murrough, JW; Nahrendorf, M; Pitman, RK; Shin, LM; Solomon, CJ; Takx, RA; Tang, CY; Tawakol, A; Truong, QA | 1 |
| Eiber, M; Fendler, WP; Herrmann, K; Stief, CG | 1 |
| Alongi, P; Baldissera, EM; De Cobelli, F; Fallanca, F; Gianolli, L; Incerti, E; Manfredi, AA; Mason, JC; Papa, M; Picchio, M; Sabbadini, MG; Sartorelli, S; Tombetti, E; Tombolini, E | 1 |
| Abela, GS; Berger, K; Durga, S; Janoudi, A; Pervaiz, MH | 1 |
| Baerlecken, NT; Bengel, FM; Daehnrich, C; Derlin, T; Ernst, D; Schlumberger, W; Schmidt, RE; Weiberg, D; Witte, T | 1 |
| Anantharajah, A; Benson, W; Berglund, LJ; Chandratilleke, D; Vicaretti, M | 1 |
| Bauckneht, M; Marini, C; Morbelli, S; Orengo, AM; Sambuceti, G | 1 |
| Eckstein, HH; Essler, M; Krause, BJ; Pelisek, J; Reeps, C; Seidl, S | 1 |
| Law, I; Louring-Andersen, J | 1 |
| Braun, J; Brewer, S; Chen, L; Fujiwara, D; McPherson, M; Takedatsu, H; Targan, SR; Turovskaya, O; Wei, B; Ziring, D | 1 |
| Al-Nahhas, A; Harari, OA; Jawad, A | 1 |
| Abdul Jalil, N; Abdul Rahim, N; Md Shalleh, N; Rossetti, C | 1 |
| Blankensteijn, JD; Bredie, SJ; Kurvers, HA; Oyen, WJ; Truijers, M | 1 |
| Ghinoi, A; Palmisano, A; Pipitone, N; Salvarani, C; Vaglio, A; Versari, A | 1 |
| Hicks, RJ | 1 |
| Goldsmith, SJ; Vallabhajosula, S | 1 |
| Dumarey, N; Gemmel, F; Welling, M | 1 |
| Alavi, A; Basu, S; Chryssikos, T; Moghadam-Kia, S; Torigian, DA; Zhuang, H | 1 |
| Appelbaum, DE; Bunnag, AP; Gavzy, SJ; Huo, D; Rubin, DT; Schnell, KM; Surma, BL | 1 |
| Chun, EJ; Goo, JM; Kang, WJ; Kim, KG; Lee, CH; Lee, HJ; Park, CM | 1 |
| Carkaci, S; Cristofanilli, M; Dawood, S; Gonzalez Angulo, AM; Le-Petross, HT; Macapinlac, HA; Mawlawi, O; Resetkova, E; Rohren, E; Yang, WT | 1 |
| De Vries, EF; Signore, A; Soroa, VA | 1 |
| Benetos, A; Djaballah, W; Dolivet, G; Joly, L; Koehl, G; Mandry, D; Marie, PY | 1 |
| Alavi, A; Basu, S; Chen, W; Rosenbaum, J; Torigian, DA; Zhuang, H | 1 |
| Imaizumi, T; Narula, J; Tahara, N; Virmani, R | 1 |
| Badimon, L; Carvajal, A; Fernandez, A; Font, MA; Gamez, C; Krupinski, J; Slevin, M | 1 |
| Chen, X; Song, J; Xing, Y; Zhao, J | 1 |
| Albert, H; Høilund-Carlsen, PF; Manniche, C; Pedersen, H | 1 |
| Chang, CH; Chang, CW; Chang, TJ; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ; Wu, CY | 1 |
| Hirata, K; Inubushi, M; Kamibayashi, T; Okamoto, S; Sato, M; Shiga, T; Tamaki, N; Tanimura, K | 1 |
| Dong, S; Huang, G; Liu, P; Wan, L | 1 |
| Chino, A; Fujisaki, J; Fujita, R; Hayashi, Y; Igarashi, M; Ishiyama, A; Kato, K; Koyama, M; Kuraoka, K; Ohkawa, N; Takahashi, H; Tsuchida, T; Ueki, N; Ukawa, K; Uragami, N; Yamamoto, Y; Yamashita, T; Yoshimoto, K | 1 |
| Cheong, SJ; Jeong, HJ; Kim, DW; Kim, EM; Kim, SL; Lee, CM; Lim, ST; Sohn, MH; Yim, CY | 1 |
| Cornily, JC; Fayad, ZA; Feldman, LJ; Hyafil, F; Machac, J; Rudd, JH | 1 |
| Aidi, HE; Farkouh, M; Fayad, ZA; Fuster, V; Mani, V; Rudd, JH; Silvera, SS; Yang, L | 1 |
| Berthou, C; Bodet-Milin, C; Cambefort, P; Campion, L; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S; Moreau, A; Moreau, P; Salaun, PY | 1 |
| Del Biondo, E; Knockaert, DD; Ruttens, D; Van Boxelaer, I; Vanderschueren, S; Wauters, E | 1 |
| Däbritz, J; Foell, D; Frosch, M; Jasper, N; Loeffler, M; Weckesser, M | 1 |
| Han, DL; Jiang, WR; Yu, JM | 1 |
| Fukuda, H; Goto, R; Inoue, K; Kinomura, S; Okada, K | 1 |
| Alberini, JL; Cherel, P; Fourme, E; Gontier, E; Le Stanc, E; Lerebours, F; Madar, O; Pecking, AP; Wartski, M | 1 |
| Ahn, SH; Cheon, GJ; Choi, CW; Chun, KS; Kang, JH; Lee, TS; Lim, SM; Moon, BS | 1 |
| Bartenstein, P; Cyran, CC; Foerster, S; Hacker, M; Nikolaou, K; Reiser, MF; Rominger, A; Saam, T; Schmidt, M; Wolpers, S | 1 |
| Aigbirhio, FI; Bird, JL; Davenport, AP; Davies, JR; Figg, N; Fryer, TD; Izquierdo-Garcia, D; Richards, HK; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
| Bansilal, S; Farkouh, ME; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rudd, JH; Woodward, M | 1 |
| Abraham, MR; Bengel, FM; Javadi, MS; Lardo, AC; Lautamäki, R; Merrill, J; Nekolla, SG; Sasano, T; Schuleri, KH; Youssef, A | 1 |
| Shah, PK | 1 |
| Aikawa, E; Figueiredo, JL; Hembrador, S; Keliher, E; Kelly, K; Libby, P; Nahrendorf, M; Panizzi, P; Weissleder, R; Zhang, H | 1 |
| Ito, K; Kubota, K; Kurihara, K; Mimori, A; Mitsumoto, T; Morooka, M; Takahashi, Y; Yamashita, H | 1 |
| Bayless, TM; Ginsburg, P; Jacene, HA; Kwon, J; Montgomery, EA; Nguyen, GC; Wahl, RL | 1 |
| Andersson, H; Eich, T; Eriksson, O; Felldin, M; Foss, A; Korsgren, O; Kyllönen, L; Langstrom, B; Lundgren, T; Nilsson, B; Sundin, A; Tibell, A; Tufveson, G | 1 |
| Carvalho, C; Higgens, CS; Russell, AI; Schreiber, BE; Tam, HH; Wong, WL | 1 |
| Ahlen, M; Berman, DS; Cheng, VY; Slomka, PJ; Thomson, LE; Waxman, AD | 1 |
| Baik, SH; Choi, DS; Choi, KM; Kim, NH; Kim, S; Kim, SG; Kim, TN; Seo, JA; Yang, SJ; Yoo, HJ | 1 |
| Andres, E; Braun, JJ; Constantinesco, A; Federici, L; Hansmann, Y; Imperiale, A; Kessler, R; Lefebvre, N; Pfumio, F | 1 |
| Kai, H | 1 |
| Brambilla, E; Calabrese, F; Lunardi, F; Rea, F; Valente, M; Zucchetta, P; Zuin, A | 1 |
| Bhojani, MS; Chenevert, TL; Galbán, CJ; Johnson, TD; Koeppe, RA; Kuszpit, KK; Lee, KC; Meyer, CR; Moffat, BA; Ranga, R; Rehemtulla, A; Ross, BD; Van Dort, ME | 1 |
| Costa, EL; Harris, RS; Jones, HA; Musch, G; Schroeder, T; Venegas, JG; Vidal Melo, MF; Winkler, T | 1 |
| Graebe, M; Højgaard, L; Kjaer, A; Pedersen, SF; Sillesen, H | 1 |
| Cabrera, AR; Chen, L; Han, A; Han, D; Li, Y; Ma, L; Ma, Y; Mu, D; Sun, X; Teng, X; Yu, J; Yue, J; Zhao, S; Zhao, X; Zheng, F; Zheng, J | 1 |
| Bartenstein, P; Becker, A; Cumming, P; Foerster, S; Greif, M; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T; Wolpers, S | 1 |
| Georgakarakos, E; Ioannou, C; Katsamouris, A; Kostas, T | 1 |
| Chandrashekhar, Y; Narula, J | 1 |
| Fayad, ZA; Glover, DK; Johnson, LL; Lanza, GM; Sadeghi, MM | 1 |
| Gillard, JH; Sadat, U; Tang, TY; Walsh, SR | 1 |
| Bundschuh, RA; Dobritz, M; Eckstein, HH; Essler, M; Gurdan, M; Ockert, S; Pelisek, J; Reeps, C; Zimmermann, A | 1 |
| Beanlands, RS; Dilsizian, V; Gropler, RJ; Lewandowski, ED; Villanueva, FS; Ziadi, MC | 1 |
| Bianco, A; Brunese, L; Di Marco, R; Gasperi, M; Mazzarella, G; Rocco, D | 1 |
| Fayad, ZA; Fuster, V; Klimas, M; Machac, J; Narula, J; Rudd, JH; Strauss, HW; Tahara, N; Tawakol, AA; Virmani, R; Warburton, EA | 1 |
| Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
| Christensen, JD; Colby, TV; Patz, EF | 1 |
| Borgwardt, L; Graebe, M; Højgaard, L; Kjaer, A; Sillesen, H | 1 |
| Campos, Cde M; da Cunha, AL; do Prado, LF; do Vale, GF; dos Anjos, DA; Santos, AC; Sobrinho, AB | 1 |
| Israel, O; Keidar, Z; Rabkin, Z | 1 |
| Chen, CH; Hsieh, MS; Lee, CJ; Tseng, SH; Wang, CC; Wang, KT | 1 |
| Baron, JC; Fryer, TD; Gillard, JH; Graves, MJ; Izquierdo-Garcia, D; Moustafa, RR; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
| Boterberg, T; Ceelen, W; Goethals, I; Ham, H; Smeets, P; Verstraete, K | 1 |
| Comans, EF; Hartemink, KJ; Muller, S; Petrousjka van den Tol, M; Smulders, YM | 1 |
| Hiari, N; Rudd, JH | 1 |
| Banziger-Tobler, NE; Detmar, M; Honer, M; Kaspar, M; Mumprecht, V; Neri, D; Proulx, ST; Schibli, R; Trachsel, E; Vigl, B | 1 |
| Hicks, RJ; Hofman, MS | 1 |
| Alavi, A; Basu, S; Saboury, B; Werner, T | 1 |
| Aschoff, P; Oksüz, MO; Pfannenberg, C; Werner, MK | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Kim, NH; Kim, S; Kim, SG; Seo, JA; Yang, SJ; Yoo, HJ | 1 |
| Morelec, I; Zenone, T; Zenou, E | 1 |
| Bellani, G; Guerra, L; Mauri, T; Messa, C; Musch, G; Patroniti, N; Pesenti, A; Zanella, A | 1 |
| Rogers, IS; Tawakol, A | 1 |
| Aractingi, S; Avril, MF; Boitier, F; Guégan, S; Kerob, D; Khosrotehrani, K; Mansard, S; Maubec, E; Merheb, C; Moguelet, P; Mortier, L; Nassar, D; Nguyen Huu, S; Oster, M; Prignon, A; Richard, MA | 1 |
| Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K | 1 |
| Bhargava, P; Rahman, S; Wendt, J | 1 |
| Bartenstein, P; Cyran, C; Dichgans, M; Gerdes, LA; Habs, M; Hacker, M; Linn, J; Nikolaou, K; Pfefferkorn, T; Reiser, M; Rominger, A; Saam, T; Schmidt, C; Straube, A | 1 |
| Bordes, S; Joshi, F; Rosenbaum, D; Rudd, JH | 1 |
| Fu, Z; Han, A; Hu, M; Huang, C; Kong, L; Xing, L; Yang, W; Yu, J; Zhang, P | 1 |
| Alavi, A; Antigua, J; Baer, A; Foroughi, N; Gelfand, JM; Krishnamoorthy, P; Mehta, NN; Raper, A; Saboury, B; Torigian, DA; Van Voorhees, AS; Yu, Y | 1 |
| Hong, JH; Kim, SE; Lee, JK; Lee, KW; Lee, NW; Song, SH | 1 |
| Choi, BW; Kim, HW; Kim, SH; Kim, SJ; Won, KS; Zeon, SK | 1 |
| Brady, TJ; Figueroa, A; Hoffmann, U; Marincheva-Savcheva, G; Qadir, S; Subramanian, S; Tawakol, A; Truong, Q; Vijayakumar, J | 1 |
| Apostolova, I; Derlin, T; Habermann, CR; Klutmann, S; Mester, J; Papp, L; Tóth, Z; Wisotzki, C | 1 |
| Servaes, S | 1 |
| Christen, T; Di Carli, MF; Folco, EJ; Libby, P; Rocha, VZ; Sheikine, Y; Shvartz, E; Sukhova, GK | 1 |
| Nguyen, PK; Wu, JC | 1 |
| Costa, EL; de Prost, N; Harris, RS; Musch, G; Tucci, MR; Venegas, JG; Vidal Melo, MF; Wellman, T; Winkler, T | 1 |
| Kaste, SC | 1 |
| Knudsen, LS; Loft, A; Nielsen, SD; Pedersen, TI; Roed, C; Skinhoj, P | 1 |
| Drent, M; Erckens, RJ; Mostard, RL; Nelemans, PJ; van Kroonenburgh, MJ; Verschakelen, JA; Vöö, S; Wijnen, PA | 1 |
| Chan, C; Guha, A; Houle, S; McLarty, K; McLaurin, J; Moran, MD; Mukherjee, J; Nitz, M; Reilly, RM; Sabha, N; Scollard, DA; Vasdev, N; Wilson, AA | 1 |
| Afshar, R; Cho, J; de Prost, N; Hamilos, DL; Harris, RS; Kone, M; Luster, AD; Medoff, BD; Musch, G; Venegas, JG; Vidal Melo, MF; Winkler, T; Wongviriyawong, C | 1 |
| Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Roytman, M; Rudd, JH; Tsimikas, S; Vucic, E | 1 |
| Finn, AV; Tawakol, A | 1 |
| Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H | 1 |
| Marwick, TH; Narula, J | 1 |
| Brady, TJ; Cury, RC; Figueroa, AL; Gardecki, JA; Hoffmann, U; Subramanian, SS; Tawakol, A; Tearney, GJ; Truong, QA | 1 |
| Boon, NA; Clark, JC; Dweck, MR; Fletcher, AM; Jones, C; Joshi, NV; Marsden, M; McKillop, G; Newby, DE; Pessotto, R; Richardson, H; Rudd, JH; Salter, DM; van Beek, EJ; Wallace, WA; White, A | 1 |
| Bucerius, J; Calcagno, C; Duivenvoorden, R; Farkouh, ME; Fayad, ZA; Fuster, V; Machac, J; Mani, V; Moncrieff, C; Rudd, JH | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Hwang, SY; Kim, NH; Kim, S; Kim, SG; Kim, TN; Seo, JA; Yang, SJ; Yoo, HJ | 1 |
| Casagrande, V; Federici, M; Gentileschi, P; Hribal, ML; Lauro, D; Lauro, R; Marino, A; Marzano, V; Menghini, R; Menini, S; Pugliese, G; Sbraccia, P; Schillaci, O; Urbani, A | 1 |
| Carruthers, D; Croft, AP; Giovanni, G; Gordon, C; Khair, O; Situnayake, D; Sivaguru, A | 1 |
| Amigoni, M; Bellani, G; Belloli, S; Di Grigoli, G; Fazio, F; Messa, C; Moresco, RM; Pesenti, A; Scanziani, M; Valtorta, S; Zambelli, V | 1 |
| Chaigne, B; Favelle, O; Magnant, J; Maillot, F; Rousselot, C | 1 |
| Marcus, DM; Shim, H; Shu, HK; Zhu, A | 1 |
| Hoit, BD; Longenecker, CT | 1 |
| Carson, RE; Dellagioia, N; Hannestad, J; Pittman, B; Planeta-Wilson, B; Subramanyam, K; Weinzimmer, D | 1 |
| Bomanji, J; Haroon, A; Zumla, A | 1 |
| Aksamit, AJ; Britton, JW; Cascino, GD; Klein, C; Kotsenas, AL; Lagerlund, TD; Lennon, VA; McKeon, A; Nickels, KC; Noe, KH; Pittock, SJ; Quek, AM; Shin, C; So, E; Watson, RE; Wirrell, EC; Worrell, GA | 1 |
| Barry, M; Crowe, M; Dolan, E; Foran, P; Grant, T; Hannon, N; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Moroney, J; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K; Sheehan, OC | 1 |
| Boellaard, R; Bruijnen, ST; Dijkmans, BA; Hoekstra, OS; Klein, JP; van Denderen, JC; van der Horst-Bruinsma, IE; van der Laken, CJ; van der Weijden, MA; Voskuyl, AE | 1 |
| Arens, AI; de Geus-Oei, LF; Hendrickx, BW; Oyen, WJ; Verbist, BM | 1 |
| Fujii, H; Hayakawa, T; Imai, T; Kimura, S; Mutoh, M; Tsuda, K; Umeda, IO; Wakabayashi, K; Yoshimoto, M | 1 |
| Ali, MS; Kong, FL; Rollo, A; Smith, DL; Yang, DJ; Yu, DF; Zhang, Y | 1 |
| Ghobrial, I; Giardino, A; Howard, S; Jagannathan, J; Krajewski, K; O'Regan, K; Ramaiya, N; Zukotynski, K | 1 |
| Bartenstein, P; Dahmen, A; Galle, PR; Goetz, M; Helisch, A; Holtmann, MH; Mudter, J; Neurath, MF; Schreckenberger, M; Uenzen, M | 1 |
| Kotsenas, AL | 1 |
| Love, C; Palestro, CJ | 1 |
| Aliyev, A; Asa, S; Halac, M; Kabasakal, L; Ocak, M; Ozhan, M; Sager, S; Sonmezoglu, K; Yılmaz, S | 1 |
| Bal, C; Kumar, R; Malhotra, A; Naswa, N; Nazar, AH; Sharma, P; Soundararajan, R | 1 |
| Buck, AK; Buck, D; Drzezga, A; Förschler, A; Hemmer, B; Korn, T; Krause, BJ; Lapa, C; Nessler, S; Schuster, T; Stadelmann, C; Vollmar, P; Wester, HJ; Zimmer, C | 1 |
| Arai, S; Fukuda, T; Kurasawa, K; Maezawa, R; Okada, H; Owada, T | 1 |
| Bimonte-Nelson, H; Braden, BB; Emerson Lombardo, N; Engler-Chiurazzi, E; Garcia, AN; Kusne, Y; LaFerla, F; Lue, L; Moses, GS; Tran, H; Valla, J; Walker, DG; Wolf, AB; Young, N | 1 |
| Kato, K; Okada, M; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Wakizaka, H; Yoshida, C; Zhang, MR | 1 |
| Balzani, A; Bonelli, N; Castellani, M; Dore, R; Gerundini, P; Longhi, S; Martinelli, I; Messa, P; Moroni, G | 1 |
| Abbara, S; Abdelbaky, A; Burdo, TH; Corsini, E; Grinspoon, SK; Hoffmann, U; Lo, J; Subramanian, S; Tawakol, A; Vijayakumar, J; Wei, J; Williams, KC; Zanni, MV | 1 |
| Amin, R; Charron, M; Ciet, P; Graniel, K; Grasemann, H; Grinblat, L; Ratjen, F; Shammas, A; Tiddens, H | 1 |
| Fayad, ZA; Millon, A; Rosenbaum, D | 1 |
| Grutters, JC; Keijsers, RG; van den Heuvel, DA | 1 |
| Habu, M; Kitamura, C; Kito, S; Kodama, M; Koga, H; Kokuryo, S; Kubota, K; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Muraoka, K; Nakashima, K; Nishino, T; Oda, M; Seta, Y; Takahashi, T; Tanaka, T; Tominaga, K; Wakasugi-Sato, N; Yamamoto, N; Yamashita, Y | 1 |
| Beanlands, RS; Cocker, MS; Dekemp, RA; Hammond, RR; Lum, C; Mc Ardle, B; McDonald, MA; Ongaro, DC; Spence, JD; Tardif, JC | 1 |
| Goldman, S | 1 |
| Huang, T; Liang, X; Nie, D; Tang, G; Wang, H; Wu, K; Yi, C | 1 |
| Basu, S; Shejul, Y | 1 |
| Ben-Nun, A; Simansky, D; Soudack, M; Yelin, A | 1 |
| Bhattacharya, A; Khaliq, A; Kochhar, R; Mittal, BR; Sharma, S | 1 |
| Buscombe, J; Chiti, A; Christian, PE; Delbeke, D; Donohoe, KJ; Israel, O; Jamar, F; Martin-Comin, J; Signore, A | 1 |
| Alavi, A; Cheng, G; Torigian, DA; Zhuang, H | 1 |
| Balink, H; Brandenburg, A; Houtman, PM; Spoorenberg, A; Verberne, HJ | 1 |
| Adam, LE; Alavi, A; Alberini, JL; Bhargava, P; Gupta, N; Hickeson, M; Zhuang, H | 1 |
| Calamia, KT; Klauser, A; Moncayo, R; Salvarani, C; Schirmer, M; Wenger, M | 1 |
| Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Mertens, J | 1 |
| Bleeker-Rovers, CP; Corstens, FH; de Kleijn, EM; Oyen, WJ; van der Meer, JW | 1 |
| Mansi, L; Oyen, WJ | 1 |
| Buscombe, J; Signore, A | 1 |
| Alavi, A; Kung, JW; Zhuang, H | 1 |
| Chen, DL; Ferkol, T; Richard, JC; Schuster, DP | 1 |
| Gan, MQ; Luo, L; Tang, GH; Tang, XL; Wang, MF | 1 |
| Biswal, S; Deroose, C; Gambhir, SS; Min, JJ | 1 |
| Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
| Choudhury, M; Harris, DN; Jones, HA | 1 |
| Alavi, A; El-Haddad, G; Gupta, N; Zhuang, H | 1 |
| Ishii, G; Murakami, K; Nagai, K; Niho, S; Nishimura, M; Nishiwaki, Y; Suzuki, K; Takamochi, K; Yoshida, J | 1 |
| Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Marengo, M; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Zinzani, P | 1 |
| Belhocine, T; Brink, I; De Deyn, PP; Flamen, P; Roland, J; Van der Borght, T; Weiner, SM | 1 |
| Alavi, A; Yu, JQ; Zhuang, H | 1 |
| Hellwig, D; Kirsch, CM; Menger, MD; Menges, M; Moellers, MO; Romeike, BF; Samnick, S; Schneider, G | 1 |
| Anaissie, E; Ferris, EJ; Jones-Jackson, L; McLaren, SG; Miceli, M; Nelson, CL; Purnell, G; Skinner, RA; Smeltzer, MS; Suva, LJ; Thomas, JR; Walker, R | 1 |
| Higashi, T; Ishimori, T; Ishizu, K; Kitaichi, M; Li, M; Mamede, M; Manabe, T; Nakamoto, Y; Saga, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Chang, WC; Fan, KH; Hsu, HT; Jan, ML; Kao, PF; Lee, TW; Shen, YC; Sun, YL | 1 |
| Keng, GH; Lim, JW; Tang, CL | 1 |
| Bonab, AA; Carter, EA; Dragotakes, SC; Mariani, G; Pellegrino, D; Pitman, JT | 1 |
| Lardinois, D; Moch, H; Roudas, M; Stahel, RA; Steinert, HC; Tutic, M; von Schulthess, GK; Weder, W | 1 |
| Cho, SH; Chung, N; Ha, JW; Ko, YG; Lee, JD; Rim, SJ; Yun, M | 1 |
| Davies, JR; Narula, J; Rudd, JH; Weissberg, PL | 1 |
| Deol, P; Kuo, PH; Monchamp, T | 1 |
| Bleeker-Rovers, CP; Corstens, FH; Kullberg, BJ; Oyen, WJ; Vos, FJ | 1 |
| Palestro, CJ; Rini, JN | 1 |
| Haaparanta, M; Knuuti, J; Laine, VJ; Laitinen, I; Leppänen, P; Marjamäki, P; Roivainen, A; Savisto, N; Soini, SL; Wilson, I; Ylä-Herttuala, S | 1 |
| De Winter, O; Goethals, I; Noens, L; Smeets, P | 1 |
| Hoffmann, U; Tatò, F; Weiss, M | 1 |
| Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Wada, Y; Watanabe, Y; Yamamoto, A | 1 |
| Alavi, A; Basu, S | 1 |
| Hatano, K; Ishino, S; Ito, K; Kato, T; Magata, Y; Mukai, T; Ogawa, M; Saji, H; Shiomi, M | 1 |
| Bashian, GG; Bedri, S; Brady, TJ; Cury, RC; Fischman, AJ; Furie, K; Gewirtz, H; Houser, S; LaMuraglia, GM; Migrino, RQ; Muller, JE; Tawakol, A; Vermylen, D; Yates, D | 1 |
| Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kai, H; Kaida, H; Nakaura, H; Tahara, N | 1 |
| Meller, J; Sahlmann, CO; Scheel, AK | 1 |
| Phelps, ME; Radu, CG; Shelly, SM; Shu, CJ; Witte, ON | 1 |
| Matsusita, M; Takagishi, K; Takeuchi, K | 1 |
| Hamazawa, Y; Inoue, Y; Koyama, K; Okamura, T; Okuma, T; Wada, Y; Wakasa, T; Watanabe, Y | 1 |
| Bellani, G; Harris, RS; Melo, MF; Musch, G; Petersen, B; Schroeder, T; Venegas, JG; Winkler, T | 1 |
| Even-Sapir, E; Metser, U | 1 |
| Alexanderson, E; Arauz, A; Hoyos, L; Mendoza, R; Zenteno, M | 1 |
| Bol, A; Geets, X; Grégoire, V; Lee, JA; Lonneux, M | 1 |
| Amthauer, H; Denecke, T; Hänninen, EL; Staeck, O | 1 |
| Chen, YK; Kao, CH; Shen, YY; Sun, SS | 1 |
| Dilege, S; Ece, T; Erelel, M; Halac, M; Mudun, A; Sonmezoglu, K; Toker, A; Turkmen, C; Yilmazbayhan, D | 1 |
| Chen, CH; Lin, PW; Liou, TH; Liu, RS; Pan, LC | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rafique, A; Rudd, JH | 1 |
| Albring, J; Berdel, WE; Bremer, C; Franzius, C; Hermann, S; Kienast, J; Köhler, G; Kucharzik, T; Löffler, M; Opitz, C; Poremba, C; Schäfers, M; Schlösser, V; Schober, O; Silling, G; Stelljes, M; Volkmann, S | 1 |
| Kanegae, K; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Tamaki, N; Yi, M; Zhao, S; Zhao, Y | 1 |
| Dunphy, MP; Strauss, HW | 1 |
| Andrès, E; Blaison, G; Blondet, C; Christmann, D; Constantinesco, A; Federici, L; Goichot, B; Imperiale, A; Pasquali, JL; Pflumio, F; Sibilia, J; Weber, JC | 1 |
| Fukuda, H; Ido, T; Kiyosawa, M; Matsuzawa, T; Sato, T; Takahashi, T; Watanuki, S; Yoshioka, S | 1 |
| Ido, T; Kubota, K; Kubota, R; Tamahashi, N; Yamada, S | 1 |
| Larson, SM | 1 |
| Fuller, RW; Hayes, M; Hill, AA; Hughes, JM; Jones, HA; Jones, T; O'Connor, BJ; O'Shaughnessy, KM; Pride, NB; Rhodes, CG; Taylor, IK | 1 |
| Hautzel, H; Müller-Gärtner, HW | 1 |
| Elomaa, I; Joensuu, H; Leskinen, S; Minn, H; Nuutinen, JM; Salminen, E; Söderström, KO; Solin, O; Varpula, M | 1 |
| Peters, AM | 1 |
| Alavi, A; Benard, F; Farber, LA; Hustinx, R; Machtay, M; Rosenthal, DI; Smith, RJ | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Oehr, P; Ruhlmann, J | 1 |
| Hikosaka, K; Hosokawa, M; Kato, T; Kohanawa, M; Kuge, Y; Mochizuki, T; Tamaki, N; Tsukamoto, E; Zhao, S | 1 |
| Boerman, OC; Corstens, FH; Oyen, WJ; Rennen, HJ | 1 |
| Alavi, A; Albelda, SM; Lambright, ES; Lanuti, M; Li, P; Mozley, PD; Pourdehnad, M; Rossman, MD; Yamamoto, AJ; Zhuang, H | 1 |
| Bohuslavizki, KH; Buchert, R; Jenicke, L; Weiner, GM | 1 |
| Adam, LE; Alavi, A; Cortés-Blanco, A; Lee, JH; Loman, JC; Martínez-Lázaro, R; Pourdehnad, M; Rossman, MD; Yamamoto, AJ; Zhuang, HM | 1 |
| Hikosaka, K; Hosokawa, M; Kanegae, K; Kohanawa, M; Kuge, Y; Mochizuki, T; Tamaki, N; Tsukamoto, E; Zhao, S | 1 |
| Blockmans, D; Bobbaers, H; Maes, A; Mortelmans, L; Stroobants, S | 1 |
| Higashi, T; Ishimori, T; Kobayashi, H; Konishi, J; Mamede, M; Nakamoto, Y; Saga, T; Sato, N | 1 |
| Buck, A; Gottschalk, J; Kaim, AH; Kurrer, MO; Von Schulthess, GK; Weber, B | 1 |
| Hikosaka, K; Hosokawa, M; Kato, T; Kohanawa, M; Kuge, Y; Mochizuki, T; Nakada, K; Tamaki, N; Tsukamoto, E; Zhao, S | 1 |
| Antoun, N; Arch, BN; Clark, JC; Davenport, AP; Fryer, TD; Johnström, P; Jones, HA; Kirkpatrick, PJ; Pickard, JD; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
| De Winter, F; Dierckx, RA; Gemmel, F; Vogelaers, D | 1 |
109 review(s) available for fluorodeoxyglucose f18 and Inflammation
| Article | Year |
|---|---|
Potential novel imaging targets of inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2022 |
Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2021 |
Role of Fluorodeoxyglucose-PET in Interventional Radiology.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiology, Interventional; Radiopharmaceuticals | 2022 |
Utility of PET/Computed Tomography in Infection and Inflammation Imaging.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review.
Topics: Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Stenosis; Cholesterol, LDL; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Plaque, Atherosclerotic | 2022 |
Rheumatic disorders among patients with fever of unknown origin: A systematic review and meta-analysis.
Topics: Adult; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Prospective Studies; Retrospective Studies; Rheumatic Diseases | 2022 |
[Hybrid PET/MRI for inflammatory cardiomyopathy].
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers; Brain Ischemia; Brazil; Cardio-Renal Syndrome; Cholestasis, Intrahepatic; Colorectal Neoplasms; Cyclin-Dependent Kinase 8; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Female; Fluorides; Fluorine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Ganciclovir; Glutamates; Heart; Hematopoietic Stem Cell Transplantation; Heterografts; HIV Infections; Humans; Inflammation; Ischemia; Kidney; Lower Extremity; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Positron-Emission Tomography; Potassium Channels; Pregnancy; Pregnancy Complications; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Retrospective Studies; Sodium; Stem Cell Transplantation; Stroke; Structure-Activity Relationship; Systole; Tetraethylammonium; Tissue Distribution; Transplantation, Autologous; Varicose Veins; Vena Cava, Inferior | 2023 |
Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2022 |
Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Inflammation; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Atherosclerosis Imaging: Positron Emission Tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Multimodality imaging of large-vessel vasculitis.
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Takayasu Arteritis | 2023 |
FDG-PET findings associated with various medical procedures and treatments.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
FDG PET in Evaluation of Patients With Fever of Unknown Origin:
Topics: Child; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.
Topics: Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Positron Emission Tomography Computed Tomography | 2023 |
Imaging Fibrosis.
Topics: COVID-19; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET.
Topics: Fluorodeoxyglucose F18; Graves Disease; Graves Ophthalmopathy; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Imaging Carotid Plaque Inflammation Using Positron Emission Tomography: Emerging Role in Clinical Stroke Care, Research Applications, and Future Directions.
Topics: Animals; Coleoptera; Constriction, Pathologic; Fluorodeoxyglucose F18; Inflammation; Plaque, Amyloid; Plaque, Atherosclerotic; Positron-Emission Tomography; Stroke | 2023 |
Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Dogs; Edema; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Machine Learning; Macrophages; Magnetic Resonance Imaging; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography | 2020 |
Patient Preparation and Patient-related Challenges with FDG-PET/CT in Infectious and Inflammatory Disease.
Topics: Anticoagulants; Blood Glucose; Cardiomyopathies; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Infections; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urologic Diseases | 2020 |
PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Vascular Diseases | 2020 |
Infection and Inflammation Imaging: Beyond FDG.
Topics: Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Molecular Probe Techniques; Organometallic Compounds; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Receptors, Cell Surface; Sensitivity and Specificity | 2020 |
PET/Computed Tomography in the Evaluation of Fever of Unknown Origin and Infectious/Inflammatory Disease in Pediatric Patients.
Topics: Adolescent; Child; Communicable Diseases; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The application of molecular imaging to advance translational research in chronic inflammation.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Radiopharmaceuticals; Stress, Psychological; Translational Research, Biomedical | 2021 |
Diagnosis of cardiac sarcoidosis: a primer for non-imagers.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
PET Imaging of Post-infarct Myocardial Inflammation.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Myocardial Infarction; Myocardium; Positron-Emission Tomography | 2021 |
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Acquisition, Processing, and Interpretation of PET
Topics: Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Likely Common Role of Hypoxia in Driving
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2021 |
Current Status of Molecular Imaging in Inflammatory and Autoimmune Disorders.
Topics: Autoimmune Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography | 2018 |
New methods to image unstable atherosclerotic plaques.
Topics: Annexin A5; Apoptosis; Atherosclerosis; Coronary Artery Disease; Diagnostic Imaging; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Inflammation; Ligands; Magnetic Resonance Imaging; Myocardial Infarction; Neovascularization, Physiologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2018 |
Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.
Topics: Cardiology; Cardiomyopathies; Disease Progression; Fibrosis; Fluorodeoxyglucose F18; Heart Failure; Humans; Inflammation; Myocardium; Regeneration | 2019 |
Molecular imaging of coronary inflammation.
Topics: Clinical Decision-Making; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors | 2019 |
Contribution of 18F-FDG PET/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: a meta-analysis.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Diet-Modulated Lipoprotein Metabolism and Vascular Inflammation Evaluated by
Topics: Animals; Apolipoproteins B; Atherosclerosis; Diet; Fluorodeoxyglucose F18; Humans; Inflammation; Lipoproteins; Lipoproteins, LDL; Macrophages; Positron-Emission Tomography; Vasculitis | 2018 |
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.
Topics: Algorithms; Cardiology; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2019 |
In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection.
Topics: Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Magnetic Resonance Imaging; Multimodal Imaging; Musculoskeletal Diseases; Musculoskeletal System; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Takayasu Arteritis; Vasculitis | 2019 |
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis.
Topics: Alzheimer Disease; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Neurodegenerative Diseases; Neuroimaging; Positron-Emission Tomography; Prospective Studies | 2019 |
The impact of infection and inflammation in oncologic
Topics: Animals; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
[IgG4-related disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Autoimmune Diseases; Cytokines; Diagnosis, Differential; Dose-Response Relationship, Drug; Eosinophilia; Fibrosis; Fluorodeoxyglucose F18; Humans; Hypersensitivity; Immunoglobulin G; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Prednisolone; Recurrence; Rituximab; Th2 Cells; Tomography, X-Ray Computed | 2013 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Rupture, Spontaneous; Sodium Fluoride; Tomography, X-Ray Computed | 2013 |
Hypoxia in atherosclerosis and inflammation.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Lipid Metabolism; Macrophages; Magnetic Resonance Angiography; Plaque, Atherosclerotic; Radiography; Signal Transduction | 2013 |
The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
FDG PET imaging in sarcoidosis.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Positron-Emission Tomography; Sarcoidosis | 2013 |
Advanced imaging of cardiac sarcoidosis.
Topics: Cardiomyopathies; Clinical Trials as Topic; Fluorodeoxyglucose F18; Heart Diseases; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2014 |
Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases.
Topics: Bacteremia; Defibrillators, Implantable; Diabetic Foot; Discitis; Early Diagnosis; Endocarditis; Fever of Unknown Origin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Meta-Analysis as Topic; Multimodal Imaging; Osteomyelitis; Pacemaker, Artificial; Positron-Emission Tomography; Predictive Value of Tests; Prosthesis-Related Infections; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
PET imaging of inflammation in atherosclerosis.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Diagnostic criteria in renal and hepatic cyst infection.
Topics: Abdominal Pain; Cysts; Fever; Fluorodeoxyglucose F18; Humans; Inflammation; Kidney; Kidney Diseases; Liver Diseases; Multimodal Imaging; Nephrology; Polycystic Kidney, Autosomal Dominant; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Novel imaging strategies for upper gastrointestinal tract cancers.
Topics: Diagnostic Imaging; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aorta, Thoracic; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiography; Vasculitis | 2014 |
PET imaging of inflammation.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
PET imaging of atherosclerosis.
Topics: Atherosclerosis; Calcinosis; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Inflammation; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2015 |
Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Topics: Algorithms; Atherosclerosis; Carotid Arteries; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Likelihood Functions; Magnetic Resonance Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.
Topics: Algorithms; Atherosclerosis; Blood Glucose; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG PET/CT in infection and inflammation--current and emerging clinical applications.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT in Infectious and Inflammatory Diseases.
Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism | 2014 |
18-Fluoro-deoxyglucose-PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders: Value to Patient Management.
Topics: Disease Management; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation.
Topics: Contrast Media; Endocarditis; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Leukocytes; Magnetic Resonance Imaging; Multimodal Imaging; Musculoskeletal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Vasculitis | 2015 |
Immunoglobulin G4-Related Disease: Recent Advances in Pathogenesis and Imaging Findings.
Topics: Autoimmune Diseases; Diagnosis, Differential; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Inflammation; Magnetic Resonance Imaging; Multiple Organ Failure; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Imaging unstable plaque.
Topics: Animals; Arteries; Calcinosis; Cardiovascular Diseases; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Magnetic Resonance Imaging; Mice; Molecular Probes; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2016 |
Monitoring Vasculitis with 18F-FDG PET.
Topics: Adult; Aged; Algorithms; Animals; Atherosclerosis; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Systemic Vasculitis; Takayasu Arteritis; Vasculitis; Whole Body Imaging | 2016 |
New molecular probes of vascular inflammation.
Topics: Animals; Apoptosis; Atherosclerosis; Calcinosis; Cardiology; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Mice; Molecular Probes; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Translational Research, Biomedical | 2016 |
F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.
Topics: Cardiomyopathies; Endocarditis; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Pericarditis; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
Topics: Animals; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunoglobulin G; Infections; Inflammation; Leukocytes; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Future diagnostic agents.
Topics: Animals; Anti-Infective Agents; Antibodies; Bacterial Infections; Cytokines; Fluorodeoxyglucose F18; Fungi; Humans; Immunoglobulin Fragments; Infections; Inflammation; Leukocytes; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Positron emission tomography as a diagnostic tool in infection: present role and future possibilities.
Topics: Acquired Immunodeficiency Syndrome; Cardiovascular Infections; Diabetic Foot; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Osteomyelitis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed | 2009 |
Functional imaging of inflammatory diseases using nuclear medicine techniques.
Topics: Animals; Clinical Medicine; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Nuclear Medicine; Radioactive Tracers; Radiography; Radionuclide Imaging | 2009 |
Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.
Topics: Annexin A5; Atherosclerosis; Carotid Stenosis; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Inflammation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium | 2009 |
[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
Topics: Dideoxynucleosides; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Imaging atherosclerosis and vulnerable plaque.
Topics: Animals; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Extracellular Matrix; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Risk; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Imaging myocardial metabolic remodeling.
Topics: Animals; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Inflammation; Kinetics; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Myocardium; Phenotype; Positron-Emission Tomography; Technetium; Tomography, Emission-Computed, Single-Photon | 2010 |
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
Topics: Animals; Arteries; Atherosclerosis; Biopsy, Needle; Cohort Studies; Coronary Artery Disease; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Severity of Illness Index | 2010 |
FDG PET imaging and cardiovascular inflammation.
Topics: Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2011 |
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.
Topics: Drug Monitoring; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Thoracic Diseases; Tomography, X-Ray Computed | 2011 |
Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.
Topics: Algorithms; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Vascular imaging with positron emission tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Macrophages; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET-CT in children: where is it appropriate?
Topics: Child; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Infections; Inflammation; Neoplasms; Pediatrics; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Application of metabolic PET imaging in radiation oncology.
Topics: Acetates; Carbon Radioisotopes; Carcinoma; Choline; Confounding Factors, Epidemiologic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lymphoma; Male; Methionine; Molecular Imaging; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2012 |
Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond.
Topics: Atherosclerosis; Brachial Artery; Carotid Intima-Media Thickness; Coronary Vessels; Endothelium, Vascular; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Magnetic Resonance Angiography; Molecular Imaging; Plaque, Atherosclerotic; Radiography; Tomography, Emission-Computed; Tomography, Optical Coherence | 2012 |
Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Multimodality imaging in amyloidosis.
Topics: Amyloidosis; Brain; Diagnostic Imaging; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoroscopy; Heart; Hematologic Neoplasms; Humans; Inflammation; Joints; Lung; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Viscera | 2012 |
Imaging of posterior element axial pain generators: facet joints, pedicles, spinous processes, sacroiliac joints, and transitional segments.
Topics: Bursitis; Edema; Fluorodeoxyglucose F18; Humans; Inflammation; Low Back Pain; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sacroiliac Joint; Spinal Diseases; Synovitis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Zygapophyseal Joint | 2012 |
Decreased sensitivity of (18)F-fluorodeoxyglucose imaging in infection and inflammation.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Sensitivity and Specificity | 2012 |
Molecular imaging in atherosclerosis: FDG PET.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Positron-Emission Tomography | 2012 |
Imaging the inflammatory activity of sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[Positron emission tomography in inflammatory disorders].
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Inflammation Mediators; Positron-Emission Tomography | 2012 |
When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Positron-Emission Tomography; Time Factors | 2013 |
Positron emission tomography imaging in nonmalignant thoracic disorders.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Lymph Nodes; Lymphatic Diseases; Pleural Diseases; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Diseases; Tomography, Emission-Computed | 2002 |
18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.
Topics: Aged; Alzheimer Disease; Animals; Aortic Aneurysm; Arteriosclerosis; Autoimmune Diseases; Fever of Unknown Origin; Fluorodeoxyglucose F18; Geriatrics; Humans; Inflammation; Models, Animal; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Implications of PET based molecular imaging on the current and future practice of medicine.
Topics: Animals; Bone Diseases; Cardiovascular Diseases; Central Nervous System; Fluorodeoxyglucose F18; Humans; Inflammation; Isotope Labeling; Neoplasms; Practice Patterns, Physicians'; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed | 2004 |
Molecular imaging for pediatric lung diseases.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Gene Expression; Genes, Reporter; Humans; Inflammation; Lung Diseases; Radiopharmaceuticals | 2004 |
Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders.
Topics: Bacterial Infections; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Severity of Illness Index | 2004 |
Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Infections | 2005 |
False positive F-18 fluorodeoxyglucose combined PET/CT scans from suture granuloma and chronic inflammation: report of two cases and review of literature.
Topics: Adult; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Inflammation; Laparotomy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sigmoid Neoplasms; Sutures; Tomography, X-Ray Computed | 2005 |
Radionuclide imaging for the detection of inflammation in vulnerable plaques.
Topics: Animals; Apoptosis; Atherosclerosis; Fluorodeoxyglucose F18; Foam Cells; Humans; Inflammation; Macrophages; Matrix Metalloproteinases; Monocytes; Phagocytosis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
FDG-PET for imaging of non-osseous infection and inflammation.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Enhancement; Infections; Inflammation; Osteitis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Imaging of infection and inflammation with 18F-FDG-labeled leukocytes.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Enhancement; Infections; Inflammation; Leukocytes; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
A case of SAPHO (synovitis-acne-pustulosis-hyperostosis-osteomyelitis) syndrome in which [18F]fluorodeoxyglucose positron emission tomography was useful for differentiating from multiple metastatic bone tumors.
Topics: Acquired Hyperostosis Syndrome; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Osteolysis; Osteosclerosis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2007 |
Molecular imaging of atherosclerosis.
Topics: Arteriosclerosis; Biotechnology; Fluorodeoxyglucose F18; History, 20th Century; Humans; Inflammation; Integrins; Lipid Metabolism; Lipoproteins, LDL; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
The use of nuclear medicine in infections.
Topics: Biomarkers; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Infections; Inflammation; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Exametazime | 1998 |
New concepts in infection/inflammation imaging.
Topics: Animals; Cytokines; E-Selectin; Fluorodeoxyglucose F18; Granulocytes; Humans; Infections; Inflammation; Tomography, Emission-Computed | 2001 |
Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Osteomyelitis; Prosthesis-Related Infections; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
39 trial(s) available for fluorodeoxyglucose f18 and Inflammation
| Article | Year |
|---|---|
Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis.
Topics: Anti-Bacterial Agents; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; United States | 2021 |
Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study.
Topics: Anti-Inflammatory Agents; Biomarkers; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rosuvastatin Calcium | 2022 |
Bone marrow activation in response to metabolic syndrome and early atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.
Topics: Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Psoriasis; Severity of Illness Index; Treatment Outcome | 2022 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
Topics: Anti-Inflammatory Agents; Arteritis; Atherosclerosis; Biomarkers; C-Reactive Protein; Canada; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Humans; Inflammation; Interleukin-6; Ischemic Attack, Transient; Multicenter Studies as Topic; Positron Emission Tomography Computed Tomography; Prediabetic State; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stroke; Tomography, X-Ray Computed | 2023 |
Topics: Colitis, Ulcerative; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging | 2020 |
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients.
Topics: Aorta, Abdominal; Arthritis, Rheumatoid; Calcinosis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2020 |
COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.
Topics: Aged; Aged, 80 and over; COVID-19; Female; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Lung; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2021 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Periodontal treatment and vascular inflammation in patients with advanced peripheral arterial disease: A randomized controlled trial.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Peripheral Arterial Disease; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Home-Based Exercise Training in Childhood-Onset Takayasu Arteritis: A Multicenter, Randomized, Controlled Trial.
Topics: Adolescent; Age of Onset; Biomarkers; Body Composition; Child; Cytokines; Exercise; Exercise Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Intra-Abdominal Fat; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Takayasu Arteritis; Young Adult | 2021 |
Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
Topics: Adult; Case-Control Studies; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Inflammation; Iodine Radioisotopes; Male; Orbit; Positron Emission Tomography Computed Tomography | 2017 |
Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.
Topics: Adult; Biomarkers; C-Reactive Protein; Crohn Disease; Feces; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Leukocyte L1 Antigen Complex; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Severity of Illness Index | 2017 |
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Carotid Arteries; Double-Blind Method; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Pyrroles; Treatment Outcome | 2013 |
Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism.
Topics: Adult; Cross-Over Studies; Cytokines; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Memory Disorders; Positron-Emission Tomography; Spatial Memory; Temporal Lobe; Typhoid-Paratyphoid Vaccines; Young Adult | 2014 |
Varying correlation between 18F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis: implications for plaque inflammation.
Topics: Aged; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2014 |
A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
Topics: Adult; Coronary Vessels; Diet; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Inflammation; Lipids; Male; Olive Oil; Plant Oils; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Verapamil | 2014 |
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
Topics: Aorta; Aspirin; Atherosclerosis; Carotid Arteries; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hypolipidemic Agents; Inflammation; Lipids; Magnetic Resonance Spectroscopy; Male; Multimodal Imaging; Niacin; Pilot Projects; Placebos; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; p38 Mitogen-Activated Protein Kinases; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazines; United States | 2015 |
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Radiopharmaceuticals; Republic of Korea; Severity of Illness Index; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Therapeutic effects of acupuncture in patients with rheumatoid arthritis: a prospective study using (18)F-FDG-PET.
Topics: Acupuncture Therapy; Adult; Aged; Arthritis, Rheumatoid; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Knee Joint; Middle Aged; Positron-Emission Tomography; Prospective Studies | 2009 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT.
Topics: Adult; Constriction, Pathologic; Crohn Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hypertrophy; Inflammation; Laboratories; Male; Middle Aged; Muscles; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Positron emission tomography in clinical islet transplantation.
Topics: Adult; Aged; C-Peptide; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Islets of Langerhans Transplantation; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial.
Topics: Aged; Diet; Dietary Carbohydrates; Fasting; Fatty Acids; Female; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Topics: Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Squamous Cell; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
When to image carotid plaque inflammation with FDG PET/CT.
Topics: Aged; Aged, 80 and over; Biological Transport; Carotid Stenosis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Injections; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2010 |
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Aortography; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2012 |
Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans.
Topics: Adult; Amygdala; Behavior; Cerebral Cortex; Depression; Endocrine System; Endotoxins; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Inflammation; Male; Positron-Emission Tomography | 2012 |
In vivo measurement of circulating leucocyte activation in patients following cardiopulmonary bypass.
Topics: Adult; Aged; Algorithms; Cardiopulmonary Bypass; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Neutrophil Activation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aorta, Thoracic; Atherosclerosis; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Simvastatin | 2006 |
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2007 |
Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET.
Topics: Adult; Deoxyglucose; Diagnostic Errors; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
501 other study(ies) available for fluorodeoxyglucose f18 and Inflammation
| Article | Year |
|---|---|
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Topics: Aged; Biomarkers; Case-Control Studies; Cytokines; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Immunosuppressive Agents; Inflammation; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Interleukin-2; Receptors, Tumor Necrosis Factor; Risk Assessment; Sarcoidosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |
Sleep duration and vascular inflammation using hybrid positron emission tomography/magnetic resonance imaging: results from the Multi-Ethnic Study of Atherosclerosis.
Topics: Aged; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography; Sleep | 2021 |
Vascular/perivascular inflammation in IgG4-related disease.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vasculitis | 2022 |
Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
Topics: Biomarkers; Carrier Proteins; Chitinase-3-Like Protein 1; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Leukocyte L1 Antigen Complex; Membrane Proteins; Positron Emission Tomography Computed Tomography; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2022 |
Heightened splenic and bone marrow uptake of
Topics: Atherosclerosis; Bone Marrow; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Spleen | 2021 |
[Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Electrons; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
FDG-PET imaging in a child with Kawasaki disease: systemic and coronary artery inflammation without dilatation.
Topics: Child; Coronary Artery Disease; Coronary Vessels; Dilatation; Dilatation, Pathologic; Fluorodeoxyglucose F18; Humans; Inflammation; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography | 2022 |
Targeted deletion of keratin 8 in intestinal epithelial cells disrupts tissue integrity and predisposes to tumorigenesis in the colon.
Topics: Aging; Animals; Carcinogenesis; Cell Differentiation; Cell Proliferation; Colon; Diarrhea; Down-Regulation; Epithelial Cells; Fluorodeoxyglucose F18; Gene Deletion; Gene Targeting; Goblet Cells; Inflammation; Integrases; Intestines; Keratin-8; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Permeability; Phenotype; Positron-Emission Tomography | 2021 |
Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Vasculitis | 2022 |
Diagnostic value of F-18 FDG PET/CT in fever or inflammation of unknown origin in a large single-center retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging; Young Adult | 2022 |
COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT.
Topics: Aged; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; SARS-CoV-2 | 2022 |
Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke.
Topics: Biomarkers; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Intercellular Adhesion Molecule-1; Ischemic Stroke; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Stroke | 2022 |
Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut-Liver Inflammation: A Study with Positron Emission Tomography and Oral
Topics: Adipose Tissue; Animals; Brain; Fluorodeoxyglucose F18; Glucose; Hepatitis; Inflammation; Lipids; Mice; Positron-Emission Tomography | 2022 |
PET/CT imaging of spinal inflammation and microcalcification in patients with low back pain: A pilot study on the quantification by artificial intelligence-based segmentation.
Topics: Adult; Artificial Intelligence; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Low Back Pain; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis.
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Glucagon-Like Peptides; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT: Reply.
Topics: COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Systemic Inflammatory Response Syndrome | 2022 |
Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Caspase 3; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Topics: COVID-19; COVID-19 Testing; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Coupling of Inflammation and Microcalcification in the Pathogenesis of Prostate Calculi: Detection Using 18 F-NaF and 18 F-FDG PET/CT.
Topics: Adult; Calcinosis; Calculi; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Diseases; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Association between prostatic 18F-FDG uptake and lower urinary tract symptoms assessed by International Prostate Symptom Score.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Hyperplasia | 2022 |
The effects of limb laterality and age on the inflammation and bone turnover of the acromioclavicular shoulder joint: 18 F-fluorodeoxyglucose and 18 F-sodium-fluoride-PET/computed tomography study.
Topics: Adult; Bone Remodeling; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Shoulder; Shoulder Joint; Sodium; Sodium Fluoride | 2022 |
Correlation of bone marrow 2-deoxy-2-[ 18 F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer.
Topics: Bone Marrow; C-Reactive Protein; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis.
Topics: Aged; Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
PET/CT-Based Characterization of 18F-FDG Uptake in Various Tissues Reveals Novel Potential Contributions to Coronary Artery Disease in Psoriatic Arthritis.
Topics: Arthritis, Psoriatic; Biomarkers; Cardiovascular Diseases; Cohort Studies; Coronary Artery Disease; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Interleukin-6; Positron Emission Tomography Computed Tomography | 2022 |
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single-Center Prospective Study.
Topics: Disease Progression; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Prospective Studies; Takayasu Arteritis | 2023 |
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Incremental Value of 18 F-FDG-Labeled Leukocytes PET/CT Over 18 F-FDG PET/CT Scan in the Detection of Occult Infection.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Leukocytes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Ongoing vascular inflammation evaluated by
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Gliosis; Glucose; Humans; Inflammation; tau Proteins | 2022 |
A case of seronegative primary Sjögren's syndrome complicated by Takayasu arteritis in a Japanese girl.
Topics: Adolescent; Autoantibodies; East Asian People; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphadenopathy; Sjogren's Syndrome; Takayasu Arteritis | 2023 |
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2022 |
Articular
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Re: COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT.
Topics: COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Systemic Inflammatory Response Syndrome | 2022 |
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients.
Topics: Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography | 2022 |
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antibodies, Bispecific; Antibody Formation; Astrocytes; Betacoronavirus; Brucellosis; Calcium; Carps; Cell Survival; Computational Biology; Coronavirus; Coronavirus Infections; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Fish Diseases; Fish Proteins; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Guanidines; HEK293 Cells; Humans; Immunity, Innate; Inflammation; Intestines; Keto Acids; Lymphocyte Activation; Mammals; Mice; Mitochondria; Molecular Docking Simulation; Neoplasms; NF-kappa B; Phylogeny; Proteome; Reactive Oxygen Species; Receptors, Antigen, T-Cell; Sodium-Calcium Exchanger; Spinal Cord; T-Lymphocytes; Toll-Like Receptor 3; Transaminases; Transcription Factor AP-1; Vaccines, Subunit | 2022 |
Increased Lung Immune Metabolic Activity in COVID-19 Survivors.
Topics: Adult; Biomarkers; COVID-19; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Male; Middle Aged; Pneumonia; Positron Emission Tomography Computed Tomography; Survivors; Thrombosis | 2022 |
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
Topics: Adalimumab; Arrhythmias, Cardiac; Atrioventricular Block; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2022 |
[
Topics: Atherosclerosis; Benchmarking; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies | 2023 |
Recurrent type III Kounis syndrome: coronary artery inflammation assessed by 18F-fluorodeoxyglucose positron emission tomography/computer tomography.
Topics: Computers; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Kounis Syndrome; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cysts; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Hamartoma; Humans; Inflammation; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2022 |
Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study.
Topics: Atrial Fibrillation; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Incidence; Inflammation; Middle Aged; Myocarditis; Predictive Value of Tests; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Heroin Use Is Associated With Vascular Inflammation in Human Immunodeficiency Virus.
Topics: Adult; Cross-Sectional Studies; Fluorodeoxyglucose F18; Heroin; HIV; HIV Infections; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
Alteration of chronic inflammatory status by transarterial embolization in frozen shoulder evaluated by fluorine-18 fluorodeoxyglucose positron-emission tomography/computed tomography.
Topics: Bursitis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2023 |
KETO[
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Mice; Peptides; Positron-Emission Tomography; Tissue Distribution | 2023 |
Vascular Inflammation During and After Community-Acquired Pneumonia as Measured by
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Pneumonia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2023 |
Intense FDG Uptake in the Common Bile Duct Post-ERCP Mimics Acute Infectious Cholangitis.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Common Bile Duct; Fluorodeoxyglucose F18; Humans; Inflammation | 2022 |
Utility of very long fasting to detect myocardial inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fasting; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Sarcoidosis | 2023 |
Diagnostic value of FDG-PET/CT in the diagnostic work-up of inflammation of unknown origin.
Topics: Butyrylcholinesterase; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Arrest; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Sarcoidosis | 2023 |
Atypical giant cell arteritis presentations diagnosed with FDG-18 whole body PET imaging.
Topics: Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisolone | 2023 |
PET/CT Reveals Localized Inflammation in the Temporal, Vertebral, and Lower Extremity Arteries in Giant Cell Arteritis.
Topics: Aged, 80 and over; Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Lower Extremity; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
The utility of F-18 FDG PET/CT for diagnosis and response evaluation of hepatosplenic tuberculosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Immunotherapy; Inflammation; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Inflammation after catheterisation mimicking tumour with squamous cell lung carcinoma in positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Higher diagnostic yield of 18F-FDG PET in inflammation of unknown origin compared to fever of unknown origin.
Topics: Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study.
Topics: Anti-Inflammatory Agents; Arthritis, Psoriatic; Biological Factors; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prospective Studies; Psoriasis | 2023 |
Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients.
Topics: Aorta, Abdominal; Aortitis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by
Topics: Adult; Biomarkers; Fluorodeoxyglucose F18; Humans; Inflammation; Ischemic Stroke; Lipoproteins, LDL; Plaque, Atherosclerotic; Prospective Studies; Stroke | 2023 |
Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer
Topics: Animals; Fluorodeoxyglucose F18; Francisella tularensis; Gallium Radioisotopes; Inflammation; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Rabbits | 2023 |
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins.
Topics: Arteritis; Atherosclerosis; Biomarkers; Carotid Arteries; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Negative 18F-FDG-PET imaging in fever and inflammation of unknown origin: now what?
Topics: Fever; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
Topics: Adult; Dermatitis, Atopic; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography | 2023 |
Arrhythmic Mitral Valve Prolapse With Only Mild or Moderate Mitral Regurgitation: Characterization of Myocardial Substrate.
Topics: Contrast Media; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Mitral Valve Insufficiency; Mitral Valve Prolapse; Ventricular Premature Complexes | 2023 |
Longitudinal Assessment of Inflammatory Activity in Acute Type B Aortic Dissection with Integrated Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
Topics: Aged; Aorta, Thoracic; Aortic Dissection; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography | 2023 |
Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Leprosy; Leprosy, Lepromatous; Mycobacterium leprae; Neuritis; Peripheral Nervous System Diseases; Positron Emission Tomography Computed Tomography | 2023 |
Association between diagnostic outcomes and symptom pattern in fever and inflammation of unknown origin.
Topics: Fever; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation | 2023 |
Rheumatology experience with FDG PET / CT in inflammation of unknown origin: a single - centre report for determining factors associated with diagnostic precision.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rheumatology | 2023 |
Psychological stress is associated with arterial inflammation in people living with treated HIV infection.
Topics: Arteritis; Atherosclerosis; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Male; Middle Aged; Stress, Psychological | 2023 |
Novel Diagnostic Imaging Approach for Patients With Spontaneous Coronary Artery Dissection: The Utility of 18 F-FDG PET Imaging.
Topics: Coronary Angiography; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Vascular Diseases | 2023 |
The routine clinical use of fluorodeoxyglucose PET/CT to confirm treatment response in pyogenic spine infection.
Topics: Anti-Bacterial Agents; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Retrospective Studies; Spinal Diseases | 2024 |
Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genotype; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Positron emission tomography imaging of inflammation in diabetes mellitus.
Topics: Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Symptomatic Carotid Atheroma Inflammation Lumen-stenosis score compared with Oxford and Essen risk scores to predict recurrent stroke in symptomatic carotid stenosis.
Topics: Brain Ischemia; Carotid Stenosis; Cerebral Infarction; Constriction, Pathologic; Fluorodeoxyglucose F18; Humans; Inflammation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Risk Factors; Stroke | 2023 |
18 F-FDG PET/CT Reveals Localized Inflammation in Lupus Enteritis.
Topics: Colitis, Ulcerative; Enteritis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Bone Lipogranuloma Mimicking Metastatic Disease on 18F-FDG PET/CT.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2023 |
The feasibility of quantitative assessment of dynamic
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Takayasu Arteritis | 2023 |
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Gliosis; Humans; Inflammation | 2023 |
White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; C-Reactive Protein; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Vascular Endothelial Growth Factor A; White Matter | 2023 |
Prognostic Impact of Cancer Inflammation Prognostic Index for Non-small Cell Lung Cancer.
Topics: Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2023 |
Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology.
Topics: Animals; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Molecular Imaging; Myocardial Infarction | 2023 |
Fibroblast Activation Protein-Targeted PET/CT With Al
Topics: Achilles Tendon; Animals; Ankle Injuries; Fibroblasts; Fibrosis; Fluorodeoxyglucose F18; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Tendon Injuries | 2023 |
Seeking clarity: Insights from a highly effective preparation protocol for suppressing myocardial glucose uptake for PET imaging of cardiac inflammation.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Myocardium; Positron-Emission Tomography | 2020 |
PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrosis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Takayasu Arteritis; Young Adult | 2019 |
A novel method to measure vascular inflammation by [18F]fluorodeoxyglucose PET/computed tomography scanning of the aorta.
Topics: Aorta; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Vascular Diseases | 2019 |
Scrotal Fibroepithelial Polyp With Acute and Chronic Inflammation Mimics Malignancy on 18F-FDG PET/CT Imaging.
Topics: Acute Disease; Aged; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Polyps; Positron Emission Tomography Computed Tomography; Scrotum | 2019 |
Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2020 |
Functional significance of post-myocardial infarction inflammation evaluated by
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coronary Vessels; Echocardiography; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Glucose Transporter Type 4; Heart; Heart Ventricles; Image Processing, Computer-Assisted; Inflammation; Muscle Cells; Myocardial Infarction; Myocardial Perfusion Imaging; Myocytes, Cardiac; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Swine | 2020 |
Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Linear Models; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Pulse Wave Analysis; ROC Curve; Sensitivity and Specificity | 2019 |
Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism.
Topics: Adult; Aged; Arteries; Arteritis; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Hematopoiesis; Humans; Hyperaldosteronism; Inflammation; Male; Middle Aged; Monocytes; Netherlands; Positron Emission Tomography Computed Tomography | 2020 |
Can PET/CT be useful in predicting ventricular arrhythmias in Chagas Disease?
Topics: Aged; Arrhythmias, Cardiac; Chagas Disease; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Myocardium; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Risk Assessment; Tachycardia, Ventricular; Technetium Tc 99m Sestamibi; Ventricular Dysfunction | 2020 |
Complex cellular physiology underlies the use of FDG-PET imaging in investigating post-infarction remodeling.
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Swine | 2020 |
Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals | 2020 |
Characterization of glucose uptake metabolism in visceral fat by 18 F-FDG PET/CT reflects inflammatory status in metabolic syndrome.
Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Spleen | 2020 |
Expert Consensus on clinical application of FDG PET/CT in infection and inflammation.
Topics: Consensus; Expert Testimony; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Infections; Inflammation; Positron Emission Tomography Computed Tomography | 2020 |
The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Inflammation; Lactic Acid; Leukocyte Count; Lymphocyte Count; Macrophages; Male; Middle Aged; Monocytes; Neutrophils; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Cell Surface; Squamous Cell Carcinoma of Head and Neck | 2020 |
In Vivo Imaging of Inflammation and Infection 2019.
Topics: Animals; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2020 |
FDG-PET/CT diagnosis of aortitis and pseudoaneurysms.
Topics: Aged; Aneurysm, False; Aortitis; C-Reactive Protein; Cardiology; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Angiography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Patients With Inflammation of Unknown Origin.
Topics: Adult; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
[Advancing the clinical application of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in cardiovascular inflammation].
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography | 2020 |
Positron Emission Tomography: A Novel Approach to Detect Pulmonary Artery Hypertension at the Early Stage?
Topics: Fluorodeoxyglucose F18; Humans; Hypertension; Inflammation; Positron-Emission Tomography; Pulmonary Artery; Serum Albumin, Human | 2020 |
Therapy Control in a Patient With an Inflammatory Abdominal Aneurysm: Potential Pitfalls in PET/CT Imaging.
Topics: Aged; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Mice, Knockout; Plaque, Atherosclerotic; Positron-Emission Tomography | 2020 |
No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Plaque, Atherosclerotic | 2020 |
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.
Topics: Adult; Cross-Sectional Studies; Endopeptidases; Female; Fibroblasts; Fibrosis; Fluorodeoxyglucose F18; Gelatinases; Humans; Image Interpretation, Computer-Assisted; Immunoglobulin G4-Related Disease; Inflammation; Male; Membrane Proteins; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Serine Endopeptidases | 2020 |
Imaging a Fever-Redefining the Role of 2-deoxy-2-[18F]Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography in Fever of Unknown Origin Investigations.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis.
Topics: Animals; Caspase 1; Cuprizone; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Chronic Progressive; Myelin Sheath | 2021 |
18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Male; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity | 2020 |
Association of glucose uptake of visceral fat and acute myocardial infarction: a pilot
Topics: Aged; Angina, Stable; Bone Marrow; Carotid Arteries; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Intra-Abdominal Fat; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen | 2020 |
Molecular imaging of tumor-specific markers and their expression in other organs.
Topics: Animals; Biomarkers, Tumor; Cardiology; Diastole; Fibroblasts; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Ligands; Molecular Imaging; Neoplasms; Nuclear Medicine; Regeneration; Systole; Ventricular Dysfunction, Left | 2021 |
FDG-Avid Pulmonary Nodules and Tracheobronchial Mural Inflammation in IgG4-Related Disease.
Topics: Biological Transport; Child; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Inflammation; Lung Diseases; Positron Emission Tomography Computed Tomography | 2021 |
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Inflammation; Misonidazole; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Hypoxia | 2021 |
The relationship between
Topics: Aged; Body Composition; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Inflammation; Lung Neoplasms; Male; Malnutrition; Middle Aged; Nutritional Status; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Analysis | 2020 |
Topics: Acute Disease; Adult; Convalescence; Cytokines; Dengue; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Spleen; Viral Load | 2021 |
Ovarian Inflammation Mass Mimicking Recurrent Rectal Cancer 17 Years After Surgery: PET/CT and MRI Findings.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Rectal Neoplasms | 2021 |
Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Brain; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron-Emission Tomography | 2021 |
Predictive factors for dental inflammation with exacerbation during cancer therapy with FDG-PET/CT imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Risk Factors | 2021 |
Evaluation of tocilizumab for intractable Takayasu arteritis and
Topics: Antibodies, Monoclonal, Humanized; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Takayasu Arteritis; Treatment Outcome | 2021 |
Multisystem positron emission tomography: interrogating vascular inflammation, emotional stress, and bone marrow activity in a single scan.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Psychological Distress; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Tracking the progress of inflammation with PET/MRI in a canine model of myocardial infarction.
Topics: Animals; Disease Models, Animal; Dogs; Fluorodeoxyglucose F18; Gadolinium DTPA; Inflammation; Magnetic Resonance Imaging; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Efficacy of Positron Emission Tomography in distinguishing brain tumours from inflammation.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, GABA | 2020 |
Statin Therapy and Vascular Inflammation Detected by Positron Emission Tomography/Computed Tomography in Patients with Psoriasis.
Topics: Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals | 2021 |
Effect of CD47 Blockade on Vascular Inflammation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Atherosclerosis; Carotid Artery Diseases; CD47 Antigen; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
Topics: Aged; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Renal Insufficiency, Chronic; Risk Factors | 2021 |
[Abdominal pain in a man with an endovascular aortic prosthesis].
Topics: Abdominal Pain; Aged; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Fluorodeoxyglucose F18; Humans; Inflammation; Listeria monocytogenes; Listeriosis; Male; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals; Treatment Outcome | 2020 |
Metabolic alterations in a rat model of takotsubo syndrome.
Topics: Animals; Calcium; Fatty Acids; Female; Flavin-Adenine Dinucleotide; Fluorodeoxyglucose F18; Glucose; Inflammation; Malonyl Coenzyme A; Myocardium; NAD; Oxidation-Reduction; Rats; RNA; Takotsubo Cardiomyopathy | 2022 |
Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A Growing Inflammatory Mass of Gastrosplenic Ligament Mimicking Recurrent Colon Cancer on FDG PET/CT.
Topics: Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammation; Ligaments; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence | 2021 |
At Last,
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron-Emission Tomography | 2021 |
Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR.
Topics: Adolescent; Atherosclerosis; Electronic Nicotine Delivery Systems; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Smokers; Young Adult | 2021 |
Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tumor Microenvironment; Uterine Cervical Neoplasms | 2021 |
Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Leukocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sex Factors; Survival Analysis; Treatment Outcome | 2021 |
Predictors of Diagnostic Contributions and Spontaneous Remission of Symptoms Associated with Positron Emission Tomography with Fluorine-18-Fluorodeoxy Glucose Combined with Computed Tomography in Classic Fever or Inflammation of Unknown Origin: a Retrospe
Topics: Adult; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Remission, Spontaneous; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Anisocytosis Is Associated With Reduced Bone Marrow Activity Evaluated by Positron Emission Tomography.
Topics: Acute-Phase Proteins; Adult; Aorta; Bone Marrow; C-Reactive Protein; Cardiovascular Diseases; Carrier Proteins; CD4-Positive T-Lymphocytes; Cross-Sectional Studies; Erythrocyte Indices; Female; Fibrin Fibrinogen Degradation Products; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Heroin Dependence; Humans; Inflammation; Interleukin-6; Lymphocyte Activation; Male; Membrane Glycoproteins; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Spleen | 2021 |
Primary Intraosseous Squamous Cell Carcinoma of the Mandible Mimicking Inflammation on FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Male; Mandible; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
Combining Preoperative Immunoinflammatory Scores and
Topics: Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Kaplan-Meier Estimate; Lymphocytes; Male; Middle Aged; Neutrophils; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Salvage Therapy; Serum Albumin | 2021 |
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Topics: Adult; Aged; Aorta; Arthritis, Rheumatoid; Biological Therapy; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Novel non-invasive assessment of upper airway inflammation in obstructive sleep apnea using positron emission tomography/magnetic resonance imaging.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sleep Apnea, Obstructive | 2022 |
Imaging Vulnerable Plaque: A Medical Necessity or a Scientific Curiosity?
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Organometallic Compounds; Plaque, Atherosclerotic; Positron-Emission Tomography | 2017 |
Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
Topics: Adipose Tissue; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2017 |
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Topics: Animal Feed; Animals; Aortic Diseases; Apolipoprotein B-100; Atherosclerosis; Atorvastatin; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, LDL; Time Factors | 2017 |
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography.
Topics: Adult; Antirheumatic Agents; Aorta; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Phototherapy; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Radiopharmaceuticals; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2017 |
Inflammatory coronary ectasia identified by three-dimensional volume rendering of 18F-Fluorodeoxyglucose PET/CT.
Topics: Coronary Disease; Dilatation, Pathologic; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Topics: Adult; Atrioventricular Block; Coronary Angiography; Coronary Artery Disease; Female; Finland; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocardium; Observer Variation; Positron-Emission Tomography; Prevalence; Retrospective Studies; Sarcoidosis; Sex Factors; Tachycardia, Ventricular | 2019 |
Topics: Cholesterol; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Occult Renal Granulomatous Inflammatory Lesions in Granulomatosis with Polyangiitis Detected by 18F-FDG PET/CT.
Topics: Adult; Biomarkers; Female; Fever; Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Inflammation; Kidney Diseases; Positron Emission Tomography Computed Tomography | 2017 |
Using FDG-PET/CT to Detect Vascular Inflammation in Patients with Psoriasis: Where to Look? And for What??
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis | 2017 |
Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.
Topics: Atrioventricular Block; Cardiomyopathies; Female; Finland; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prevalence; Sarcoidosis | 2019 |
In vitro imaging of bacteria using
Topics: Bacillus subtilis; Bacterial Proteins; Fever; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Mutation; Phosphotransferases; Positron-Emission Tomography; Staphylococcus aureus | 2017 |
Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study.
Topics: Aging; Animals; Brain Mapping; Cerebral Cortex; Cross-Sectional Studies; Cytokines; Female; Fluorodeoxyglucose F18; Glucose; Imaging, Three-Dimensional; Inflammation; Mice; Mice, Inbred C57BL; Microglia; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA | 2017 |
Predictive value of
Topics: Aged; Aorta; Aortic Diseases; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematoma; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; ROC Curve; Sensitivity and Specificity; Vena Cava, Superior | 2019 |
Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Observer Variation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography | 2017 |
Topics: Aged, 80 and over; Aortic Dissection; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron-Emission Tomography; Time Factors; Vascular Diseases | 2018 |
Myocarditis with high
Topics: Dideoxynucleosides; Electrocardiography; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Male; Myocarditis; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2018 |
Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case report.
Topics: Amyloidosis; Anti-Bacterial Agents; Doxycycline; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron-Emission Tomography; Renal Dialysis; Treatment Outcome | 2017 |
Cre/lox-assisted non-invasive in vivo tracking of specific cell populations by positron emission tomography.
Topics: Animals; Cell Tracking; Fluorodeoxyglucose F18; Genes, Reporter; Inflammation; Integrases; Mice; Myocardial Infarction; Positron-Emission Tomography; Recombination, Genetic; T-Lymphocytes; Thymidine Kinase | 2017 |
Distinguishing Active Vasculitis From Sterile Inflammation and Graft Infection: A Call for a More Specific Imaging Target.
Topics: Cardiovascular System; Fluorodeoxyglucose F18; Humans; Inflammation; Vasculitis | 2017 |
Cardiac sarcoidosis after glucocorticoid therapy evaluated by
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis | 2018 |
Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits : An
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Male; Pioglitazone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Random Allocation; Tomography, X-Ray Computed | 2018 |
Obesity and CRP.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Obesity; Positron Emission Tomography Computed Tomography; Prospective Studies | 2018 |
How useful is PET/CT in the evaluation of fever/inflammation of unknown origin? Comment on the article by Schönau
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Dielectric imaging for differentiation between cancer and inflammation in vivo.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Inflammation; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms; Positron-Emission Tomography | 2017 |
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American
Topics: Biopsy; Cardiology; Cardiomyopathies; Diagnostic Imaging; Echocardiography; Europe; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Reproducibility of Results; Sarcoidosis; Societies, Medical; Tomography, X-Ray Computed; United States | 2018 |
The potential role of FDG PET-CT in the characterization of the activity of Crohn's disease, staging follow-up and prognosis estimation: a pilot study.
Topics: Adolescent; Adult; Colon; Colonoscopy; Crohn Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hungary; Inflammation; Linear Models; Male; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Severity of Illness Index; Tertiary Care Centers; Young Adult | 2018 |
Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?
Topics: Adiposity; Arteritis; Cohort Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Psoriasis; Risk Factors | 2018 |
Inflammatory aneurysm of ileocolic artery discovered on fluorine 18-fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Aged; Aneurysm; Arteries; Colon; Fluorodeoxyglucose F18; Humans; Ileum; Inflammation; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Streptococcal Infections | 2017 |
Novel ECG parameters are strongly associated with inflammatory
Topics: Adult; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sarcoidosis | 2017 |
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prospective Studies | 2018 |
Response to: the value of 18(F)-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Technical considerations for quantification of
Topics: Carotid Artery Diseases; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
The relationship between
Topics: Aged; Biomarkers, Tumor; Colorectal Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Inflammation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2018 |
Permanently Hypoxic Cell Culture Yields Rat Bone Marrow Mesenchymal Cells with Higher Therapeutic Potential in the Treatment of Chronic Myocardial Infarction.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Cytokines; Fluorodeoxyglucose F18; Heart; Hemodynamics; Inflammation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenotype; Positron-Emission Tomography; Rats; Rats, Wistar | 2017 |
Coronary Artery Inflammation in Rheumatoid Arthritis Using Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography.
Topics: Arthritis, Rheumatoid; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
18FDG-PET/CT for the Visualization of Inflammatory Component of Radiation-Induced Lung Injury After Stereotactic Radiotherapy.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Injury; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiosurgery | 2018 |
Inflammation: New insights from PET imaging.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Myocardial Infarction; Positron-Emission Tomography | 2018 |
Response to: 'Is the PET/CT first choice for differential diagnosis of FUO/IUO?' by Armagan
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prospective Studies | 2018 |
[
Topics: Crohn Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies | 2018 |
Imaging cellular pharmacokinetics of 18F-FDG and 6-NBDG uptake by inflammatory and stem cells.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Cell Line; Fluorodeoxyglucose F18; Glucosamine; Humans; Inflammation; Mice; Stem Cells | 2018 |
Anti-inflammatory effect of statin in coronary aneurysms late after Kawasaki disease.
Topics: Adult; Anti-Inflammatory Agents; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Coronary Artery Bypass; Coronary Vessels; Disease Progression; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography | 2019 |
Targeted Bacteria-Specific
Topics: Bacteria; Bacterial Infections; Defibrillators, Implantable; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Oligosaccharides; Positron-Emission Tomography | 2019 |
Imaging inflammation in atherosclerotic plaques: Just make it easy!
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Inflammation; Lymphocyte Function-Associated Antigen-1; Plaque, Atherosclerotic; Positron-Emission Tomography | 2019 |
Feasibility of Imaging Inflammation in the Left Atrium Post AF Ablation Using PET Technology.
Topics: Aged; Atrial Fibrillation; Catheter Ablation; Cryosurgery; Feasibility Studies; Fluorodeoxyglucose F18; Heart Atria; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Pulmonary Veins | 2017 |
Editorial: Molecular Imaging of Inflammation/Infection: The Future of Disease Management.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography | 2018 |
Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery.
Topics: Acute Coronary Syndrome; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies | 2020 |
Topics: Computer Simulation; Cross-Over Studies; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Intestinal Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Scleroderma, Systemic | 2018 |
18F-FDG PET/CT in an Atypical Case of Relapsed IgG4-Related Disease Presenting as Inflammatory Pseudotumor in Gall Bladder Fossa With Extensive Disease Involvement.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Humans; Immunoglobulin G; Inflammation; Male; Positron Emission Tomography Computed Tomography; Recurrence | 2018 |
Spatial Heterogeneity of Lung Strain and Aeration and Regional Inflammation During Early Lung Injury Assessed with PET/CT.
Topics: Animals; Endotoxemia; Female; Fluorodeoxyglucose F18; Gene Expression; Immune System Phenomena; Inflammation; Lung Injury; Microarray Analysis; Organ Size; Positron Emission Tomography Computed Tomography; Prone Position; Radiopharmaceuticals; Respiration, Artificial; Sheep; Supine Position | 2019 |
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Inflammation Coupling Between Unstable Carotid Plaque and Spleen-A
Topics: Aged; Carotid Artery, Internal; Carotid Stenosis; Case-Control Studies; Endarterectomy, Carotid; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Magnetic Resonance Imaging; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rupture, Spontaneous; Spleen | 2018 |
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Topics: Acute Disease; Animals; Autoimmune Diseases; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew | 2019 |
A 1-week extension of a ketogenic diet provides a further decrease in myocardial
Topics: Animal Feed; Animals; Diet, Carbohydrate-Restricted; Diet, Ketogenic; Dietary Carbohydrates; Fasting; Fluorodeoxyglucose F18; Heart; Heart Diseases; Inflammation; Male; Myocarditis; Myocardium; Myosins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Swine | 2020 |
Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.
Topics: Adult; Aorta; Computed Tomography Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis | 2018 |
Aging alters glucose uptake in the naïve and injured rodent spinal cord.
Topics: Aging; Animals; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Glucose Transporter Type 3; Glucose Transporter Type 4; Inflammation; Male; Positron-Emission Tomography; Rats; Spinal Cord; Spinal Cord Injuries | 2019 |
Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis.
Topics: Animals; Biological Transport; Biomarkers; CD11b Antigen; Colitis; Disease Models, Animal; Fluorodeoxyglucose F18; Immunity, Innate; Immunoconjugates; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2019 |
The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Risk; Sarcoidosis; Tomography, X-Ray Computed | 2020 |
Multimodal imaging of cardiac-calcified amorphous tumor.
Topics: Aged; Contrast Media; Echocardiography; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Inflammation; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Chronic Vasitis After Mesh Herniorrhaphy: A Potential Cause of False Positive Results in 18F-FDG PET/CT Studies.
Topics: Aged; Chronic Disease; False Positive Reactions; Fluorodeoxyglucose F18; Herniorrhaphy; Humans; Incidental Findings; Inflammation; Male; Positron Emission Tomography Computed Tomography; Vas Deferens | 2019 |
The validity of
Topics: Animals; Biomarkers; Biopsy; Blood-Brain Barrier; Brain; Brain Neoplasms; Carbazoles; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genotype; Humans; Indoles; Inflammation; Ligands; Loperamide; Multiple Sclerosis; Positron-Emission Tomography; Protein Binding; Purines; Receptors, GABA; Reproducibility of Results; Verapamil | 2019 |
18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications.
Topics: Aged; Autoimmune Diseases; Cohort Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Mass Screening; Middle Aged; Muscular Diseases; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Heart; Heart Atria; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Stroke | 2019 |
Glucose-6-phosphatase Expression-Mediated [
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphatase; Humans; Inflammation; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; RAW 264.7 Cells | 2019 |
Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Heart; Humans; Imaging, Three-Dimensional; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2020 |
Inflammatory Activity of Tumoral Calcinosis in a Patient With Fever of Unknown Origin.
Topics: Calcinosis; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Contrast-enhanced Ultrasonography for Monitoring Arterial Inflammation in Takayasu Arteritis.
Topics: Adult; Arteries; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Severity of Illness Index; Takayasu Arteritis; Ultrasonography; Young Adult | 2019 |
Signal intensity of superb micro-vascular imaging associates with the activity of vascular inflammation in Takayasu arteritis.
Topics: Adolescent; Edema; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Microcirculation; Positron Emission Tomography Computed Tomography; Takayasu Arteritis; Tomography, X-Ray Computed | 2020 |
18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging.
Topics: Adolescent; Basal Ganglia; Brain; Child; Child, Preschool; Encephalitis; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Inflammation; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
One-stop shopping
Topics: Adult; Behcet Syndrome; Collateral Circulation; Computed Tomography Angiography; Edema; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Imaging, Three-Dimensional; Inflammation; Positron Emission Tomography Computed Tomography; Subclavian Vein; Tomography, X-Ray Computed; Vascular Diseases; Vena Cava, Superior | 2019 |
Arterial Inflammation: The Heat Before the Storm.
Topics: Arteritis; Atherosclerosis; Fluorodeoxyglucose F18; Hot Temperature; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography | 2019 |
FDG PET imaging of vascular inflammation in post-traumatic stress disorder: A pilot case-control study.
Topics: Adult; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stress Disorders, Post-Traumatic; Vasculitis | 2021 |
The neuro-hematopoietic-inflammatory arterial axis: The missing link between PTSD and cardiovascular disease?
Topics: Cardiovascular Diseases; Fluorodeoxyglucose F18; Hematopoietic System; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Stress Disorders, Post-Traumatic | 2021 |
Characterization of a highly effective preparation for suppression of myocardial glucose utilization.
Topics: Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Myocardium; Peptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Breast; Breast Implants; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Rupture; Urinary Bladder Neoplasms; Urothelium | 2019 |
Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohi
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
Serial non-invasive assessment of antibody induced nephritis in mice using positron emission tomography.
Topics: Animals; Autoantibodies; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Inflammation; Kidney; Kidney Function Tests; Mice; Multimodal Imaging; Nephritis; Organ Size; Positron-Emission Tomography; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2013 |
Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
Topics: Chronic Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.
Topics: Cooperative Behavior; Europe; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Societies, Medical | 2013 |
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Contrast Media; Dextrans; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiography; Radiopharmaceuticals; Time Factors | 2013 |
FDG PET in the early diagnosis of large-vessel vasculitis.
Topics: Diffusion; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Remission Induction; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2013 |
Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Artery Diseases; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Rupture, Spontaneous; Stroke | 2013 |
Whole body assessment by ¹⁸F-FDG PET in a patient with infective endocarditis.
Topics: Adult; Echocardiography, Transesophageal; Endocarditis; Fever; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Mitral Valve; Mitral Valve Insufficiency; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Differential washout of FDG activity in two different inflammatory lesions: implications for delayed imaging.
Topics: Aged; Fluorodeoxyglucose F18; Granuloma; Humans; Inflammation; Joints; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
18F-FDG PET finding of an inflammatory abdominal aortic aneurysm leading to fatal rupture: case report.
Topics: Aortic Aneurysm, Abdominal; Aortic Rupture; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hermanski-Pudlak Syndrome; Humans; Inflammation; Male; Microscopy, Confocal; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals | 2013 |
Imaging findings of inflammatory pseudotumor-like follicular dendritic cell tumor of spleen.
Topics: Adult; Dendritic Cells, Follicular; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2014 |
Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.
Topics: Biological Transport; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2013 |
Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model.
Topics: Animals; Fluorodeoxyglucose F18; Folic Acid; Inflammation; Positron-Emission Tomography | 2013 |
Neovascularization in the carotid atherosclerotic plaque is not associated with inflammatory cell aggregation.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cell Aggregation; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Lung [(18)F]fluorodeoxyglucose uptake and ventilation-perfusion mismatch in the early stage of experimental acute smoke inhalation.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Inflammation; Lung; Positron-Emission Tomography; Radiopharmaceuticals; Sheep; Smoke Inhalation Injury | 2014 |
Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
Topics: Acute Disease; Adult; Aged; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Retrospective Studies; Time Factors | 2013 |
Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiation Pneumonitis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques.
Topics: Aged; Brain Ischemia; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Radionuclide Imaging; Radiopharmaceuticals; Stroke | 2013 |
Statin therapy resolves coronary artery inflammation.
Topics: Adult; Anti-Infective Agents; Biomarkers; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Multidetector Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Quinolines; Treatment Outcome | 2013 |
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Animals; Carboxylic Acids; Cell Line, Tumor; Cyclobutanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hydrogen-Ion Concentration; Inflammation; Male; Methionine; Prostatic Neoplasms; Rats | 2014 |
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.
Topics: Adult; Aged; Aorta; Blood Glucose; Cardiovascular Diseases; Carotid Arteries; Fasting; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venae Cavae | 2014 |
Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Endarterectomy, Carotid; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2014 |
Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Myocardium; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Treatment Outcome; Ventricular Function, Left | 2014 |
Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.
Topics: Adipose Tissue; Aged; Arteries; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Obesity; Pericardium; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Early inflammation mainly affects normally and poorly aerated lung in experimental ventilator-induced lung injury*.
Topics: Animals; Blood Gas Analysis; Fluorodeoxyglucose F18; Hematologic Tests; Hemodynamics; Inflammation; Lung; Neutrophils; Positron-Emission Tomography; Pulmonary Gas Exchange; Radiopharmaceuticals; Swine; Ventilator-Induced Lung Injury | 2014 |
Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
Topics: Amides; Anticholesteremic Agents; Coronary Artery Disease; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Anti-inflammatuar and anti-oxidative effects of Nigella sativa L.: 18FDG-PET imaging of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catalase; Disease Models, Animal; Fluorodeoxyglucose F18; Inflammation; Lipopolysaccharides; Liver; Liver Function Tests; Lung; Nigella sativa; Positron-Emission Tomography; Rats; Superoxide Dismutase | 2014 |
Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
Topics: Animals; Aorta; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis; Tomography, X-Ray Computed | 2014 |
Imaging myocardium at risk and coronary inflammation in non-ST-segment elevation myocardial infarction: combined use of FDG PET and optical coherence tomography.
Topics: Aged; Coronary Angiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Optical Coherence | 2015 |
PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.
Topics: Animals; Brain; Brain Injuries; Carrier Proteins; Disease Models, Animal; Fluorodeoxyglucose F18; Gene Expression Regulation; Inflammation; Ligands; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Rats; Receptors, GABA-A; Time Factors | 2014 |
Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer.
Topics: Aged; Aged, 80 and over; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arteries; Female; Fluorodeoxyglucose F18; Folate Receptor 2; Humans; Immunohistochemistry; Inflammation; Male; Mice; Middle Aged; Models, Biological; Molecular Imaging; Plaque, Atherosclerotic | 2014 |
Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation.
Topics: Adipose Tissue; Age Factors; Aged; Atrial Fibrillation; Blood Glucose; Body Mass Index; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Male; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sex Factors; Tomography, X-Ray Computed | 2014 |
Diagnostic utility of (18)F-FDG PET/CT in inflammation of unknown origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Young Adult | 2014 |
Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis.
Topics: Animals; Apolipoproteins E; Carotid Artery Diseases; Cholesterol, Dietary; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Phenotype; Plaque, Atherosclerotic; Positron-Emission Tomography | 2014 |
Serum lipids associated with inflammation-related PET-FDG uptake in symptomatic carotid plaque.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cholesterol; Cohort Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triglycerides | 2014 |
Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Topics: Animals; Bacterial Infections; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fibrosarcoma; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organometallic Compounds; Picolinic Acids; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2014 |
Effect of local tidal lung strain on inflammation in normal and lipopolysaccharide-exposed sheep*.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Inflammation; Lipopolysaccharides; Pneumonia; Positive-Pressure Respiration; Positron-Emission Tomography; Radiopharmaceuticals; Respiration, Artificial; Respiratory Function Tests; Sheep; Tidal Volume | 2014 |
Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Incidental Findings; Inflammation; Lymphatic Diseases; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The value of FDG-PET in the diagnosis of thromboangiitis obliterans--a case series.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thromboangiitis Obliterans; Treatment Outcome; Whole Body Imaging | 2015 |
Evaluation of inflamed coronary atherosclerotic plaques by PET: more evidences for a promising area of cardiovascular imaging.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Plaque, Atherosclerotic; Positron-Emission Tomography | 2014 |
Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Inflammation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2014 |
Fever of unknown origin in the 2000s: evaluation of 103 cases over eleven years.
Topics: Adult; Aged; Aged, 80 and over; DNA, Bacterial; DNA, Viral; Female; Ferritins; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2014 |
18F-FDG uptake and calcifications on positron emission tomography/computed tomography in octogenarians with severe aortic stenosis.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2015 |
In vivo evaluation of inflammatory bowel disease with the aid of μPET and the translocator protein 18 kDa radioligand [18F]DPA-714.
Topics: Animals; Colon; Dextran Sulfate; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Glucose; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Inflammatory Bowel Diseases; Ligands; Male; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2015 |
(18)F-fluorodeoxy glucose and (18)F fluoride PET for detection of inflammation focus in periprosthetic hip joint infection cases.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hip Joint; Hip Prosthesis; Humans; Inflammation; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Radionuclide Imaging; Sensitivity and Specificity | 2015 |
Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging.
Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Inflammation; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Indomethacin; Inflammation; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Photochemotherapy; Positron-Emission Tomography; Time Factors | 2014 |
Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.
Topics: Animals; Citrates; Fluorodeoxyglucose F18; Gallium; Inflammation; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Perfusion Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
Topics: Aged; Biomarkers; Capillary Permeability; Carotid Arteries; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Histocompatibility Antigens Class II; Humans; Inflammation; Inflammation Mediators; Linear Models; Macrophages; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
[18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin.
Topics: Adult; Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hospitalization; Humans; Infections; Inflammation; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Imaging systemic inflammation in patients with acute myocardial infarction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Myocardial Infarction; Myocardium | 2014 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
Topics: Aged; Arteries; Atherosclerosis; Blood Component Removal; Case-Control Studies; Cholesterol, LDL; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Hyperlipoproteinemia Type II; Inflammation; Lipoproteins; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Risk Factors; Tomography, X-Ray Computed | 2014 |
18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndrome.
Topics: Animals; Biomarkers; Disease Models, Animal; Endotoxemia; Fluorodeoxyglucose F18; Gene Expression Regulation; Inflammation; Kinetics; Lipopolysaccharides; Lung; Lung Injury; Neutrophils; Phosphorylation; Positron-Emission Tomography; Pulmonary Edema; Radiopharmaceuticals; Respiratory Distress Syndrome; Sheep; Surface-Active Agents | 2014 |
[99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Multimodal Imaging; Neutrophils; Oligopeptides; Organotechnetium Compounds; Osteomyelitis; Peptides; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Technetium Tc 99m Medronate; Tibia; Tomography, X-Ray Computed | 2015 |
Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice.
Topics: Anesthetics, General; Animals; Anticoagulants; Fasting; Fluorodeoxyglucose F18; Glucose; Heparin; Inflammation; Isoflurane; Ketamine; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Myocytes, Cardiac; Positron-Emission Tomography; Radiopharmaceuticals; Xylazine | 2015 |
The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Topics: Anilides; Animals; Biological Transport; Cell Line, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Inflammation; Macrophages; Mice; Neoplasms; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Thiazolidinediones; Tissue Distribution | 2015 |
Carotid inflammation on ¹⁸F-fluorodeoxyglucose positron emission tomography associates with recurrent ischemic lesions.
Topics: Aged; Carotid Artery Diseases; Carotid Stenosis; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Ischemia; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors | 2014 |
Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Venous Thromboembolism | 2015 |
Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT.
Topics: Aged; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Intima-Media Thickness; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Malondialdehyde; Middle Aged; Positron-Emission Tomography; Prospective Studies; Surveys and Questionnaires; Tomography, X-Ray Computed | 2014 |
Statin reduces persistent coronary arterial inflammation evaluated by serial ¹⁸fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease.
Topics: Adult; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2015 |
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Methyltyrosines; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
[Usefulness of (18)FDG PET-CT scan as a diagnostic tool of fever of unknown origin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
[The value of (18)F-FDG PET/CT in diagnosing giant cell arteritis presenting as fever of unknown origin].
Topics: Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study.
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Boston; Calcinosis; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Longitudinal Studies; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Inflammation and calcification: the chicken or the hen?
Topics: Aortic Valve; Aortic Valve Stenosis; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Can the inflammatory response be evaluated using 18F-FDG within zones of microvascular obstruction after myocardial infarction?
Topics: Animals; Coronary Circulation; Coronary Occlusion; Coronary Vessels; Dogs; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Image Processing, Computer-Assisted; Inflammation; Macrophages; Magnetic Resonance Imaging; Microcirculation; Multimodal Imaging; Myocardial Infarction; Pentetic Acid; Positron-Emission Tomography; Reproducibility of Results; Technetium; Time Factors | 2015 |
Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Creatine Kinase; Dermatomyositis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Muscle, Skeletal; Polymyositis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Syndrome; Young Adult | 2015 |
Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.
Topics: Aged; Carotid Stenosis; Endarterectomy, Carotid; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neurologic Examination; Positron-Emission Tomography; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2015 |
Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Primary Myelofibrosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Evaluation of plaque stability in extracranial carotid atherosclerotic disease: Role of vascular inflammation.
Topics: Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Ischemia; Male; Positron-Emission Tomography | 2015 |
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospecti
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Inflammation; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Solitary Pulmonary Nodule; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2015 |
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.
Topics: Aged; Arteries; Atherosclerosis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2015 |
PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR?
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography | 2015 |
The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
Topics: Adult; Aged; Blood Sedimentation; C-Reactive Protein; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Autoradiography; Biphenyl Compounds; Body Weight; Disease Progression; Fluorodeoxyglucose F18; Hyperlipidemias; Inflammation; Irbesartan; Male; Mice, Knockout; Positron-Emission Tomography; Rabbits; Renin-Angiotensin System; Tetrazoles | 2015 |
Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
Topics: Animals; Biomarkers; Blood Glucose; C-Reactive Protein; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Lipids; Male; Matrix Metalloproteinase 9; Pioglitazone; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Thiazolidinediones; Thrombosis; Tomography, X-Ray Computed | 2015 |
Plaque Inflammation Imaging in Severe Carotid Stenosis and Recurrent Cerebral Ischemia.
Topics: Brain Ischemia; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Recurrence | 2015 |
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Infliximab; Lung; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Quality of Life; Respiratory Function Tests; Sarcoidosis, Pulmonary; Treatment Outcome | 2015 |
Variability of [18F]FDG administered activities among patients undergoing PET examinations: an international multicenter survey.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Health Care Surveys; Humans; Inflammation; International Agencies; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Remodeling; Disease Progression; Female; Fluorodeoxyglucose F18; Hand Joints; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Wrist Joint | 2016 |
Implications of Pericardial, Visceral and Subcutaneous Adipose Tissue on Vascular Inflammation Measured Using 18FDG-PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Intra-Abdominal Fat; Male; Middle Aged; Pericardium; Positron-Emission Tomography; Risk Factors; Subcutaneous Fat | 2015 |
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Tomography, X-Ray Computed | 2015 |
High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
Topics: Aged; Aged, 80 and over; Carotid Arteries; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vascular Calcification | 2016 |
Concurrent Carotid Inflammation in Acute Coronary Syndrome as Assessed by (18)F-FDG PET/CT: A Possible Mechanistic Link for Ischemic Stroke.
Topics: Acute Coronary Syndrome; Aged; C-Reactive Protein; Carotid Arteries; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Leukocytes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
[A case report of suspected Stauffer syndrome presenting with fever, extensive inflammation, and abnormal liver function tests].
Topics: Biopsy; Carcinoma, Renal Cell; Fatal Outcome; Fever; Fluorodeoxyglucose F18; Humans; Inflammation; Kidney Neoplasms; Liver Diseases; Liver Function Tests; Male; Middle Aged; Positron-Emission Tomography | 2015 |
PET/CT "Virtual" Special Issue.
Topics: Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; User-Computer Interface | 2015 |
Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC).
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Inflammation; Kinetics; Lung Neoplasms; Mice; Mice, Inbred C57BL; Positron-Emission Tomography | 2015 |
Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.
Topics: Cardiomyopathies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Infections; Inflammation; Neoplasms; Nervous System Diseases; Positron-Emission Tomography; South Africa; Tomography, X-Ray Computed | 2015 |
Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Diet; Diet, Carbohydrate-Restricted; Endocarditis; Female; Fluorodeoxyglucose F18; Glucose; Heart; Heparin; Humans; Inflammation; Male; Middle Aged; Myocardium; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Young Adult | 2016 |
Comparison of three ¹⁸F-labeled carboxylic acids with ¹⁸F-FDG of the differentiation tumor from inflammation in model mice.
Topics: Animals; Benzoates; Carboxylic Acids; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorocarbons; Fluorodeoxyglucose F18; Humans; Inflammation; Mice; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2016 |
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Endothelial Cells; Female; Fluorodeoxyglucose F18; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Random Allocation; Sensitivity and Specificity; Single-Domain Antibodies; Vascular Cell Adhesion Molecule-1 | 2016 |
Role of 18F-FDG PET/CT in the diagnosis of inflammatory and infectious vascular disease.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Vascular Diseases | 2016 |
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
Topics: Adenocarcinoma; Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Differentiating Between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Glucose; Gold; Humans; Inflammation; Metal Nanoparticles; Mice; Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Comparative Analysis between [(18)F]Fludarabine-PET and [(18)F]FDG-PET in a Murine Model of Inflammation.
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Vidarabine | 2016 |
Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography.
Topics: Arrhythmias, Cardiac; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Liver; Lymph Nodes; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Young Adult | 2016 |
The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Phantoms, Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography | 2017 |
Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; E-Selectin; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; P-Selectin; Plaque, Atherosclerotic; Positron-Emission Tomography; Tissue Distribution | 2017 |
Evaluation of [(89)Zr]-Oxalate as a PET Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models.
Topics: Animals; Arthritis, Rheumatoid; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Mice; Oxalates; Positron-Emission Tomography; RAW 264.7 Cells | 2016 |
The dream of imaging coronary artery inflammation with FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
False-Positive Finding on 18F FDG PET/CT: Report of a Rare Case With Xanthogranulomatous Inflammation in the Spinal Epidural Space.
Topics: Diagnosis, Differential; Epidural Space; False Positive Reactions; Fluorodeoxyglucose F18; Granuloma; Humans; Inflammation; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Xanthomatosis | 2016 |
[
Topics: Adult; Aorta; Calcinosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Sodium Fluoride; Takayasu Arteritis; Young Adult | 2017 |
Inflammatory involvement in a patient with Leriche syndrome evaluated by
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Leriche Syndrome; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
18F-FDG Imaging of Chronic Inflammation Associated With Promontofixation of the Uterus.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Laparoscopy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Surgical Mesh; Uterine Prolapse | 2017 |
Differential Regulation of Macrophage Glucose Metabolism by Macrophage Colony-stimulating Factor and Granulocyte-Macrophage Colony-stimulating Factor: Implications for
Topics: Animals; Cell Differentiation; Cells, Cultured; Fluorodeoxyglucose F18; Glucose; Granulocyte-Macrophage Colony-Stimulating Factor; Inflammation; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Immunohistochemistry; Inflammation; Lung Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Positron Emission Tomography Assessment of Left Main Coronary Arterial Inflammation With Coronary Computed Tomographic Angiography Validation Before and After Statin Therapy: More Promise for Fluorodeoxyglucose Vascular Uptake?
Topics: Angiography; Arteritis; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Imaging Radiation-Induced Gastrointestinal, Bone Marrow Injury and Recovery Kinetics Using 18F-FDG PET.
Topics: Animals; Bone Marrow; Fluorodeoxyglucose F18; Gastrointestinal Tract; Inflammation; Kinetics; Male; Positron Emission Tomography Computed Tomography; Radiation Injuries; Rats; Rats, Sprague-Dawley | 2017 |
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.
Topics: Aged; Amygdala; Arteries; Atherosclerosis; Bone Marrow; Cardiovascular Diseases; Cross-Sectional Studies; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Inflammation; Longitudinal Studies; Middle Aged; Perception; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Risk Factors; Stress, Psychological | 2017 |
A PET for All Seasons:
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Fibrosis; Tomography, X-Ray Computed | 2017 |
Topics: Adult; Aged; Arteries; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Takayasu Arteritis; Young Adult | 2017 |
PET/CTA detection of muscle inflammation related to cholesterol crystal emboli without arterial obstruction.
Topics: Animals; Arteries; Biomarkers; Cholesterol; Computed Tomography Angiography; Crystallization; Fluorodeoxyglucose F18; Inflammation; Injections, Intra-Arterial; Microspheres; Muscle, Skeletal; Myositis; Necrosis; Plaque, Atherosclerotic; Polystyrenes; Positron-Emission Tomography; Rabbits; Thrombosis | 2018 |
Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on
Topics: Adult; Atherosclerosis; Autoantibodies; Biomarkers; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Protein Array Analysis; Radiopharmaceuticals; Serologic Tests; Severity of Illness Index; Transcription Factors | 2017 |
Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report.
Topics: Antineoplastic Agents; Carotid Arteries; Fatal Outcome; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Leukemia, Myeloid, Acute; Middle Aged; Neck Pain; Positron-Emission Tomography; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2017 |
Topics: Endocarditis; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms.
Topics: Acute Disease; Aged; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric | 2008 |
The effects of bone erosion from aortic aneurysm on the regional uptake of FDG.
Topics: Aged; Aortic Aneurysm; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Positron-Emission Tomography; Thoracic Vertebrae; Tomography, X-Ray Computed | 2008 |
Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Colitis; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Inflammation; Intestinal Mucosa; Intestines; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred Strains; Mice, Knockout; Piroxicam; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Necrosis Factor Ligand Superfamily Member 15 | 2008 |
18F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis.
Topics: Aged; Biopsy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Myositis; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2008 |
18F-FDG positron emission tomography/computed tomography and the "underground map" appearance in imaging Horton's arteritis.
Topics: Aged, 80 and over; Arteritis; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall.
Topics: Aged; Aortic Aneurysm, Abdominal; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Images in cardiovascular medicine. Chronic periaortitis.
Topics: Aorta, Abdominal; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Retroperitoneal Fibrosis; Vasculitis | 2008 |
Time and again, children resemble their parents.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed; Young Adult | 2009 |
Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Radiobelled white blood cells or FDG for imaging on inflammation and infection?
Topics: Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Leukocytes; Positron-Emission Tomography; Radiopharmaceuticals; Staining and Labeling; Tomography, Emission-Computed, Single-Photon | 2009 |
Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification.
Topics: Aorta; Aortography; Calcinosis; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Inflammation; Middle Aged; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2009 |
Elevated FDG uptake in right middle segmental bronchus impacted with foreign body.
Topics: Bronchi; Bronchoscopy; Cough; Diagnostic Imaging; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
PET imaging in patients with Modic changes.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2009 |
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Topics: Animals; Autoradiography; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Misonidazole; Positron-Emission Tomography; Radioactive Tracers; Sarcoma; Tissue Distribution | 2009 |
Kinetic analysis of experimental rabbit tumour and inflammation model with 18F-FDG PET/CT.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Forelimb; Inflammation; Kinetics; Neoplasm Transplantation; Neoplasms, Experimental; Rabbits; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
Topics: Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Stomach; Stomach Neoplasms | 2009 |
The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
Topics: Animals; Biological Transport; Cell Line, Tumor; Dimethyl Sulfoxide; Fluorodeoxyglucose F18; Gene Expression Regulation; Glucose; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Inflammation; Macrophages; Mice; Neoplasms; Positron-Emission Tomography; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2009 |
Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Topics: Animals; Atherosclerosis; Contrast Media; Fluorodeoxyglucose F18; Inflammation; Macrophages; Male; Positron-Emission Tomography; Rabbits; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
Topics: Aged; Atherosclerosis; Calcium; Carotid Artery Diseases; Collagen; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Inflammation; Lipids; Magnetic Resonance Angiography; Male; Middle Aged; Necrosis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Child; Diffusion; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Spleen; Tomography, X-Ray Computed; Young Adult | 2009 |
Inflammation of unknown origin versus fever of unknown origin: two of a kind.
Topics: Adult; Aged; C-Reactive Protein; Databases, Factual; Diagnosis-Related Groups; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Rheumatic Diseases | 2009 |
Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation.
Topics: Adolescent; Child; Child, Preschool; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infant; Inflammation; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity.
Topics: Age Factors; Bone Marrow; Fluorodeoxyglucose F18; Hematology; Humans; Inflammation; Liver; Middle Aged; Neoplasms; Regression Analysis; Retrospective Studies | 2009 |
Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Positron-Emission Tomography; Rats; Thymidine Phosphorylase; Tissue Distribution; Tyrosine | 2009 |
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
Topics: Aged; Arteries; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Inflammation; Male; Middle Aged; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Radiology; Risk; Sex Characteristics; Survival Analysis; Tomography, X-Ray Computed; Vascular Diseases | 2009 |
FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol, Dietary; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Male; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiopharmaceuticals | 2010 |
Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
Topics: Aged; Angiography; Arteries; Atherosclerosis; Biomarkers; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: evaluation in a porcine model of myocardial infarction.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Inflammation; Microcirculation; Myocardial Infarction; Myocardium; Nitrogen Radioisotopes; No-Reflow Phenomenon; Positron-Emission Tomography; Radiopharmaceuticals; Swine; Swine, Miniature; Tomography, X-Ray Computed | 2009 |
Imaging inflammation in atherosclerosis another step forward.
Topics: Animals; Atherosclerosis; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Inflammation; Inflammation Mediators; Ligands; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2009 |
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Binding, Competitive; Cells, Cultured; Contrast Media; Disease Models, Animal; Endothelium, Vascular; Feasibility Studies; Fluorodeoxyglucose F18; Graft Rejection; Half-Life; Heart Transplantation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Iopamidol; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; RNA, Messenger; Tissue Distribution; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2009 |
Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthrography; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
F-18 PET-CT showing large vessel vasculitis in a patient with high inflammatory markers and no localizing symptoms.
Topics: Aged; Arteries; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Tomography, X-Ray Computed; Vasculitis | 2009 |
Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adiponectin; Analysis of Variance; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Statistics, Nonparametric; Tunica Intima; Tunica Media | 2010 |
F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Pulmonary inflammatory myofibroblastic tumour with unusual octreoscan uptake: two reports.
Topics: Adult; Female; Fibroblasts; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Neoplasms, Muscle Tissue; Neuroendocrine Tumors; Pentetic Acid; Somatostatin; Tomography, X-Ray Computed | 2010 |
Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Gliosarcoma; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2010 |
Mild endotoxemia during mechanical ventilation produces spatially heterogeneous pulmonary neutrophilic inflammation in sheep.
Topics: Animals; Blood Gas Analysis; Endotoxemia; Fluorodeoxyglucose F18; Inflammation; Leukocyte Count; Lung; Neutrophils; Nitrogen Radioisotopes; Perfusion; Pneumonia; Positive-Pressure Respiration; Positron-Emission Tomography; Pulmonary Circulation; Radiopharmaceuticals; Respiration, Artificial; Sheep | 2010 |
18FDG PET and ultrasound echolucency in carotid artery plaques.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Carotid Stenosis; Cerebrovascular Disorders; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; RNA, Messenger; Severity of Illness Index; Ultrasonography, Doppler | 2010 |
Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biological Transport; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2010 |
Inflammatory response to aortic aneurysm intraluminal thrombus may cause increased 18F-FDG uptake at sites not associated with high wall stress: comment on "high levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress".
Topics: Aorta; Aortic Aneurysm; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Stress, Mechanical; Thrombosis | 2010 |
Molecular imaging of coronary inflammation: overcoming hurdles one at a time...
Topics: Acute Coronary Syndrome; Coronary Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2010 |
Comment on "Advanced carotid plaque imaging".
Topics: Biomarkers; Carotid Artery Diseases; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Nanoparticles; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
(18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Imaging of acute and chronic aortic dissection by 18F-FDG PET/CT.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Diagnosis, Differential; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fibrin Fibrinogen Degradation Products; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
FDG/PET uptake in asymptomatic multilobar Chlamydia pneumoniae pneumonia.
Topics: Adult; Anti-Bacterial Agents; Chlamydophila pneumoniae; False Positive Reactions; Female; Fluorodeoxyglucose F18; Goiter; Humans; Immunoglobulin M; Inflammation; Multiple Pulmonary Nodules; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2010 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cellular Structures; Female; Fibrosis; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Necrosis; Positron-Emission Tomography | 2010 |
Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Image Processing, Computer-Assisted; Infections; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Young Adult | 2010 |
Using 18F-FDG microPET imaging to measure the inhibitory effects of Clematis chinensis Osbeck on the pro-inflammatory and degradative mediators associated with inflammatory arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Chondrocytes; Clematis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Inflammation; Interleukin-1beta; Joints; Matrix Metalloproteinases; Phytotherapy; Plant Extracts; Plant Roots; Positron-Emission Tomography; Rabbits; Saponins | 2011 |
Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot study.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Intracranial Embolism; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stroke; Time Factors; Ultrasonography, Doppler, Transcranial | 2010 |
Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data.
Topics: Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
[Fluorodeoxyglucose F18(FDG)-probe guided biopsy].
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
Topics: Animals; Antibodies, Monoclonal; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Glycoproteins; Humans; Inflammation; Iodine Radioisotopes; Luminescent Measurements; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Melanoma, Experimental; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin; Tissue Distribution; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2010 |
Restaging: should we percist without pattern recognition?
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Neoplasm Staging; Neoplasms; Pattern Recognition, Automated; Pattern Recognition, Visual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign).
Topics: Adult; Fluorodeoxyglucose F18; Humans; Inflammation; Lacrimal Apparatus; Male; Mediastinum; Parotid Gland; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adiponectin; Adult; Analysis of Variance; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Obesity; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Republic of Korea; Resistin; Risk Assessment; Risk Factors | 2011 |
[Paraganglioma as a cause of inflammation of unknown origin: usefulness of positon emission tomography].
Topics: Blood Sedimentation; C-Reactive Protein; Cranial Nerve Neoplasms; Diagnosis, Differential; Female; Fibrinogen; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Magnetic Resonance Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Syndrome; Vagus Nerve Diseases; Young Adult | 2011 |
Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury.
Topics: Acute Lung Injury; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Lung; Male; Middle Aged; Positive-Pressure Respiration; Positron-Emission Tomography; Radiopharmaceuticals; Respiration, Artificial; Tidal Volume; Tomography, X-Ray Computed | 2011 |
Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis.
Topics: Animals; Cell Proliferation; Female; Fluorodeoxyglucose F18; Inflammation; Lymphangiogenesis; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Animal; Skin | 2011 |
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methionine; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2011 |
Atlas of confounding factors in head and neck PET/CT imaging.
Topics: Artifacts; Biological Transport; Fluorodeoxyglucose F18; Head; Humans; Image Interpretation, Computer-Assisted; Inflammation; Male; Neck; Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Vessel wall inflammation in spontaneous cervical artery dissection: a prospective, observational positron emission tomography, computed tomography, and magnetic resonance imaging study.
Topics: Adult; Arteries; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Vertebral Artery Dissection | 2011 |
Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity.
Topics: Carcinoma, Non-Small-Cell Lung; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2011 |
Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.
Topics: Adult; Aorta; Aortography; Arthrography; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Liver; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Skin; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence | 2011 |
Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Kidney Transplantation; Lymphoproliferative Disorders; Male; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging | 2011 |
Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Arteries; Biological Transport; Calcinosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Minerals; Plaque, Atherosclerotic; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Risk Factors; Sodium Fluoride; Tomography, X-Ray Computed; Young Adult | 2011 |
Imaging infection and inflammation in children with (18)F-FDG PET and (18)F-FDG PET/CT.
Topics: Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Pediatrics; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
Topics: Aorta; Atherosclerosis; Cytokines; Endothelial Cells; Fluorodeoxyglucose F18; Foam Cells; Glucose; Humans; Hydrolysis; Hypoxia; Inflammation; Macrophages; Monocytes; Myocytes, Smooth Muscle; Positron-Emission Tomography | 2011 |
Imaging atherosclerosis with F18-fluorodeoxyglucose positron emission tomography: What are we actually seeing?
Topics: Atherosclerosis; Cardiology; Clinical Trials as Topic; Cytokines; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Macrophages; Positron-Emission Tomography; Research Design | 2011 |
Effects of surfactant depletion on regional pulmonary metabolic activity during mechanical ventilation.
Topics: Animals; Bronchoalveolar Lavage; Fluorodeoxyglucose F18; Inflammation; Lung; Nitrogen Radioisotopes; Positive-Pressure Respiration; Positron-Emission Tomography; Pulmonary Surfactants; Radiopharmaceuticals; Respiration, Artificial; Sheep; Stress, Mechanical | 2011 |
Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Neopterin; Netherlands; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Interleukin-2; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
Topics: Animals; Biological Transport; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Inositol; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Positron-Emission Tomography; Radiochemistry; Transplantation, Heterologous | 2011 |
18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma.
Topics: Adult; Allergens; Animals; Asthma; Biological Transport; Biomarkers; Bronchoalveolar Lavage; Cats; Cell Count; Eosinophils; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Positron-Emission Tomography; Respiratory System; Tomography, X-Ray Computed; Ventilation-Perfusion Ratio; Young Adult | 2011 |
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortography; Atherosclerosis; Biomarkers; Contrast Media; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Inflammation; Lipids; Macrophages; Magnetic Resonance Angiography; Multimodal Imaging; Neovascularization, Pathologic; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed | 2011 |
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Artery Diseases; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Magnetic Resonance Angiography; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness?
Topics: Anti-Inflammatory Agents; Aortic Diseases; Aortography; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Iopamidol; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.
Topics: Aged; Analysis of Variance; Carotid Artery Diseases; Coronary Artery Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Linear Models; Male; Middle Aged; Multimodal Imaging; New York City; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2011 |
Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Republic of Korea; Up-Regulation | 2012 |
TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.
Topics: Adipose Tissue; Adiposity; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Diet, High-Fat; Fatty Liver; Fluorodeoxyglucose F18; Inflammation; Insulin Resistance; Macrophages; Mice; Non-alcoholic Fatty Liver Disease; Obesity; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3 | 2012 |
Refractory multisystem sarcoidosis responding to infliximab therapy.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Infliximab; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Remission Induction; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury.
Topics: Acute Lung Injury; Animals; Blood Gas Analysis; Cell Proliferation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hydrochloric Acid; Hydroxyproline; Inflammation; Linear Models; Macrophages; Mice; Neutrophil Infiltration; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; X-Ray Microtomography | 2012 |
18 FDG PET/CT contribution in occult giant-cell arteritis.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Asthenia; Biopsy; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Weight Loss | 2012 |
Autoimmune epilepsy: clinical characteristics and response to immunotherapy.
Topics: Adolescent; Adult; Aged; Autoantibodies; Brain; Cyclophosphamide; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins; Immunologic Factors; Immunotherapy; Inflammation; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nerve Tissue Proteins; Plasmapheresis; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
Topics: Aged; Carotid Stenosis; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Stroke; Tomography, X-Ray Computed | 2012 |
Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study.
Topics: Adult; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Osteogenesis; Pilot Projects; Positron-Emission Tomography; Spondylitis, Ankylosing; Tomography, X-Ray Computed; Young Adult | 2012 |
False positive 18F-FDG PET/CT due to inflamed concha bullosa.
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Turbinates | 2012 |
In vivo SPECT imaging with 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis model.
Topics: Animals; Autoradiography; Cricetinae; Disease Models, Animal; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Inflammation; Mice; Nitrosamines; Organometallic Compounds; Pancreatic Neoplasms; Peptides, Cyclic; Tomography, Emission-Computed, Single-Photon | 2012 |
Development of tyrosine-based radiotracer 99mTc-N4-Tyrosine for breast cancer imaging.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Inflammation; Mammary Neoplasms, Experimental; Organotechnetium Compounds; Radiation Dosage; Radioactive Tracers; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution; Tyrosine | 2012 |
18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.
Topics: Adult; Colonoscopy; Crohn Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2012 |
The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Leukocytes; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Staphylococcal Infections; Tomography, X-Ray Computed | 2012 |
Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin.
Topics: Causality; Comorbidity; Fever of Unknown Origin; Fluorodeoxyglucose F18; Global Health; Humans; Infections; Inflammation; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.
Topics: Animals; Cell Proliferation; Dideoxynucleosides; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorodeoxyglucose F18; Inflammation; Positron-Emission Tomography; Rats; Spinal Cord; Tyrosine | 2012 |
Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis.
Topics: Adolescent; Adult; Aged; Dermatomyositis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Polymyositis; Positron-Emission Tomography; Retrospective Studies | 2012 |
Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention.
Topics: Alzheimer Disease; Amyloidosis; Animals; Cognition; Dietary Supplements; Electron Transport Complex IV; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Nutritional Physiological Phenomena; Plant Extracts; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Sex Characteristics; Synaptophysin; tau Proteins | 2012 |
Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
Topics: Acute Disease; Aminoisobutyric Acids; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2012 |
The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
Topics: Adult; Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retroperitoneal Fibrosis; Tomography, X-Ray Computed | 2012 |
Arterial inflammation in patients with HIV.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Macrophage Activation; Male; Middle Aged; Monocytes; Positron-Emission Tomography; Receptors, Cell Surface; Risk Factors | 2012 |
Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT.
Topics: Adolescent; Anti-Bacterial Agents; Child; Cystic Fibrosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Tomography, X-Ray Computed | 2012 |
Reflection of ¹⁸F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Periodontitis; Positron-Emission Tomography | 2012 |
A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation.
Topics: Animals; Apoptosis; Cell Line, Tumor; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Mice; Positron-Emission Tomography; Radioactive Tracers; Thiazoles; Tissue Distribution; Turpentine | 2012 |
Regional lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement.
Topics: Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Lymph Nodes; Middle Aged; Peptides, Cyclic; Positron-Emission Tomography | 2014 |
Fluorodeoxyglucose--positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
Topics: Adult; Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Silicone Gels; Thoracic Surgery, Video-Assisted | 2013 |
Incidental detection of colonic inflammation on PET/CT using 18F-FDG-labeled autologous leukocytes.
Topics: Adult; Colonic Diseases; Fluorodeoxyglucose F18; Humans; Incidental Findings; Inflammation; Isotope Labeling; Leukocytes; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
Topics: Breast Feeding; Documentation; Female; Fluorodeoxyglucose F18; Health Knowledge, Attitudes, Practice; Humans; Image Interpretation, Computer-Assisted; Infection Control; Infections; Inflammation; Molecular Imaging; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Pregnancy; Quality Control; Radiation Dosage; Radiopharmaceuticals; Research Report; Safety; Social Control, Formal; Societies, Scientific; Tomography, X-Ray Computed | 2013 |
Early recognition of aortitis of the aorta ascendens with ¹⁸F-FDG PET/CT: syphilitic?
Topics: Adult; Aorta; Aortitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; HLA-B27 Antigen; Humans; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Spondylitis, Ankylosing; Syphilis, Cardiovascular; Tomography, X-Ray Computed | 2013 |
Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Topics: Amino Acids; Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Inflammation; Iodine Radioisotopes; Methyltyrosines; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution; Turpentine; Whole-Body Counting | 2003 |
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Focal Infection; Humans; Inflammation; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
FDG-PET in infectious and inflammatory disease.
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG-PET in infectious and inflammatory disease.
Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[Synthesis and radiopharmacology of S-(2-18F-fluoroethyl)-L-methionine for tumor imaging].
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Methionine; Mice; Neoplasm Transplantation; Radiopharmaceuticals; Sarcoma 180; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Tyrosine | 2003 |
Tetraphenylphosphonium as a novel molecular probe for imaging tumors.
Topics: Animals; Cell Line, Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Mice, Nude; Molecular Probes; Neoplasms; Onium Compounds; Organ Specificity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tuberculosis, Cutaneous | 2004 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
18F-FDG PET early after radiotherapy in lymphoma patients.
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
A plea for the elective inclusion of the brain in routine whole-body FDG PET.
Topics: Brain; Brain Diseases; Brain Neoplasms; Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Limbic Encephalitis; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Whole-Body Counting | 2005 |
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous | 2005 |
Early detection of bone infection and differentiation from post-surgical inflammation using 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography (FDG-PET) in an animal model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Inflammation; Male; Osteomyelitis; Positron-Emission Tomography; Postoperative Complications; Rabbits; Staphylococcal Infections | 2005 |
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Topics: Adenocarcinoma; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Neoplasm Metastasis; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Time Factors; Tuberculosis | 2005 |
Coincidence planar imaging for dynamic [18F]FDG uptake in nude mice with tumors and inflammation: correlated with histopathology and micro-autoradiography.
Topics: Animals; Autoradiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Mice; Mice, Nude; Neoplasms, Experimental; Radionuclide Imaging | 2005 |
Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Topics: Animals; Escherichia coli Infections; Fluorodeoxyglucose F18; Inflammation; Leukocytes; Male; Metabolic Clearance Rate; Pseudomonas Infections; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2005 |
Images in cardiovascular medicine. Assessment of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis with 18F-2-deoxyglucose positron emission tomography.
Topics: Aged; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Pericardial Effusion; Pericarditis, Constrictive; Positron-Emission Tomography; Treatment Outcome; Tuberculosis | 2006 |
Imaging of inflammation in Graves' ophthalmopathy by positron emission tomography/computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Graves Ophthalmopathy; Humans; Inflammation; Positron-Emission Tomography | 2006 |
Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
Topics: Animals; Aorta; Apolipoprotein B-48; Arteries; Atherosclerosis; Autoradiography; Calcinosis; Carotid Stenosis; Femoral Artery; Fluorodeoxyglucose F18; Humans; Inflammation; Mice; Mice, Knockout; Receptors, LDL; Tissue Distribution | 2006 |
Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[Takayasu's arteritis without manifest arterial stenoses as a cause of fever of unknown origin].
Topics: Arterial Occlusive Diseases; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Takayasu Arteritis | 2006 |
18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Topics: Animals; Carcinoma; Catheter Ablation; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Neoplasm Transplantation; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2006 |
Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer.
Topics: Antineoplastic Agents; Artifacts; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Radiotherapy; Time Factors; Treatment Outcome | 2007 |
Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Atherosclerosis; Body Weight; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Positron-Emission Tomography; Rabbits; Tomography, X-Ray Computed | 2006 |
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Male; Middle Aged; Positron-Emission Tomography | 2006 |
18F-FDG PET and PET/CT in fever of unknown origin.
Topics: Aged; Cell Line, Tumor; Clinical Trials as Topic; Fever of Unknown Origin; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Inflammation; Insulin; Positron-Emission Tomography; Sensitivity and Specificity; Temperature; Tomography, X-Ray Computed | 2007 |
Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Spinal Cord; Tomography, X-Ray Computed | 2007 |
Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model.
Topics: Animals; Carcinoma; Disease Models, Animal; Fluorodeoxyglucose F18; Inflammation; Neoplasms, Experimental; Positron-Emission Tomography; Rabbits; Turpentine | 2007 |
Regional gas exchange and cellular metabolic activity in ventilator-induced lung injury.
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Leukocyte Count; Lung; Neutrophil Activation; Positive-Pressure Respiration; Positron-Emission Tomography; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Sheep; Ventilators, Mechanical | 2007 |
Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Longitudinal Studies; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study.
Topics: Aged; Aged, 80 and over; Angiography; Carotid Stenosis; Cerebral Infarction; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Ischemic Attack, Transient; Male; Middle Aged; Neurologic Examination; Pilot Projects; Positron-Emission Tomography; Prognosis; Risk Factors | 2007 |
A gradient-based method for segmenting FDG-PET images: methodology and validation.
Topics: Algorithms; Cluster Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Inflammation; Pattern Recognition, Automated; Phantoms, Imaging; Polymethyl Methacrylate; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique | 2007 |
PET/CT visualises inflammatory activity of pulmonary artery aneurysms in Behçet disease.
Topics: Adult; Aneurysm; Behcet Syndrome; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Inflammation; Male; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Misdiagnosis of multiple bone metastases due to increased FDG uptake in polyostotic fibrous dysplasia.
Topics: Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Technetium; Tomography, X-Ray Computed | 2007 |
Correlation between joint [F-18] FDG PET uptake and synovial TNF-alpha concentration: a study with two rabbit models of acute inflammatory arthritis.
Topics: Animals; Arthritis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Interleukin-8; Joints; Lipopolysaccharides; Positron-Emission Tomography; Rabbits; Synovial Fluid; Synovial Membrane; Tumor Necrosis Factor-alpha | 2007 |
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Topics: Aged; Aortic Diseases; Atherosclerosis; Carotid Artery Diseases; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.
Topics: Adult; Aged; Animals; Cell Movement; Colon; Female; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Diseases; Lymphocytes; Male; Mice; Middle Aged; Positron-Emission Tomography; Prognosis; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Whole Body Imaging | 2008 |
Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Dideoxynucleosides; Fluorodeoxyglucose F18; Granuloma; Inflammation; Liver Neoplasms; Male; Methionine; Mycobacterium bovis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Turpentine | 2008 |
Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Syndrome; Tomography, X-Ray Computed | 2010 |
[Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
Topics: Animals; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Fluorine; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Rabbits; Radioisotopes; Radionuclide Imaging | 1983 |
High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.
Topics: Animals; Autoradiography; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Male; Radionuclide Imaging; Rats; Time Factors; Turpentine | 1995 |
Cancer or inflammation? A Holy Grail for nuclear medicine.
Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Allergens; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Tomography, Emission-Computed | 1996 |
Early changes in fluorine-18-FDG uptake during radiotherapy.
Topics: Aged; Carcinoma, Papillary; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Clinical PET in oncology.
Topics: Artifacts; Blood Glucose; Cooperative Behavior; Cyclotrons; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germany; Humans; Inflammation; Lymphatic Metastasis; Male; Medical Oncology; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Nuclear Medicine; Organ Specificity; Practice Guidelines as Topic; Private Practice; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Universities | 2000 |
Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
Topics: Animals; Blood Glucose; Fluorodeoxyglucose F18; Glucose; Hypoglycemic Agents; Inflammation; Insulin; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Staphylococcal Infections; Tissue Distribution | 2001 |
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Topics: Aged; Animals; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Mice; Middle Aged; Neoplasms; Radiopharmaceuticals; Rats; Rats, Inbred F344; Retrospective Studies; Tomography, Emission-Computed; Tumor Cells, Cultured | 2001 |
[FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports].
Topics: Anti-Inflammatory Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Prednisolone; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?
Topics: Blood Glucose; Fluorodeoxyglucose F18; Humans; Inflammation; Mesothelioma; Monocytes; Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tumor Cells, Cultured | 2001 |
FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
Topics: Animals; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Immunohistochemistry; Inflammation; Liver Neoplasms, Experimental; Monosaccharide Transport Proteins; Neoplasm Transplantation; Rats; Rats, Wistar; Staphylococcal Infections | 2001 |
FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.
Topics: Animals; Autoradiography; Concanavalin A; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Inflammation; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Tissue Distribution | 2002 |
Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats.
Topics: Abscess; Animals; Autoradiography; Fluorodeoxyglucose F18; Inflammation; Male; Muscle, Skeletal; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2002 |
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.
Topics: Animals; Fluorodeoxyglucose F18; Glucose; Hypoglycemic Agents; Inflammation; Insulin; Liver Neoplasms, Experimental; Male; Monosaccharide Transport Proteins; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Staphylococcal Infections | 2002 |
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |